Summary
A0A1B0GTC6
Homolog: L0GBQ6.
Function: Antimicrobial peptide Con22.
Statistics
Total GO Annotation: 551
Unique PROST Go: 551
Unique BLAST Go: 0
Total Homologs: 1355
Unique PROST Homologs: 1354
Unique BLAST Homologs: 0
Structures and Sequence Alignment
The best structural homolog that predicted by 2. P was
L0GBQ6
(Antimicrobial peptide Con22) with a FATCAT P-Value: 1.75e-06 and RMSD of 0.51 angstrom. The sequence alignment identity is 22.9%.
Structural alignment shown in left. Query protein A0A1B0GTC6 colored as red in alignment, homolog L0GBQ6 colored as blue.
Query protein A0A1B0GTC6 is also shown in right top, homolog L0GBQ6 showed in right bottom. They are colored based on secondary structures.
A0A1B0GTC6 MAYK-MLQVVLCSTLLIGALGAPFLLEDPANQFL--RLKRHVNLQDYWDPDHSSDV---WVNTLAKQARETWIALK---TTA---QYYLD--MNT-FTFD 85 L0GBQ6 MNAKVML---VC--LLV-----TMLVMEPAEAGIWSWIKK--TAKKVWNSDVAKKLKGKALN-VAKD----FVAEKIGATPAEAGQIPFDEFMNVLYS-- 81 A0A1B0GTC6 MSTAQ 90 L0GBQ6 ----- 81
Go Annotations
1. PB indicates the go terms that are found by both PROST and BLAST.2. P indicates the go terms that are found by only PROST.
3. B indicates the go terms that are only annotated by BLAST.
Source | GO | Description |
---|---|---|
2. P | GO:0007617 | mating behavior |
2. P | GO:0031652 | positive regulation of heat generation |
2. P | GO:0060621 | negative regulation of cholesterol import |
2. P | GO:0048046 | apoplast |
2. P | GO:1905333 | regulation of gastric motility |
2. P | GO:0051216 | cartilage development |
2. P | GO:0120020 | cholesterol transfer activity |
2. P | GO:0009410 | response to xenobiotic stimulus |
2. P | GO:0008283 | cell population proliferation |
2. P | GO:0060230 | lipoprotein lipase activator activity |
2. P | GO:0006641 | triglyceride metabolic process |
2. P | GO:0010900 | negative regulation of phosphatidylcholine catabolic process |
2. P | GO:0043011 | myeloid dendritic cell differentiation |
2. P | GO:0001976 | nervous system process involved in regulation of systemic arterial blood pressure |
2. P | GO:1904055 | negative regulation of cholangiocyte proliferation |
2. P | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion |
2. P | GO:0005183 | gonadotropin hormone-releasing hormone activity |
2. P | GO:0060192 | negative regulation of lipase activity |
2. P | GO:0150076 | neuroinflammatory response |
2. P | GO:0050995 | negative regulation of lipid catabolic process |
2. P | GO:0001964 | startle response |
2. P | GO:0019221 | cytokine-mediated signaling pathway |
2. P | GO:0002438 | acute inflammatory response to antigenic stimulus |
2. P | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
2. P | GO:0032713 | negative regulation of interleukin-4 production |
2. P | GO:0030334 | regulation of cell migration |
2. P | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway |
2. P | GO:1901046 | positive regulation of oviposition |
2. P | GO:0032097 | positive regulation of response to food |
2. P | GO:0019731 | antibacterial humoral response |
2. P | GO:0008289 | lipid binding |
2. P | GO:0009749 | response to glucose |
2. P | GO:0031704 | apelin receptor binding |
2. P | GO:0006959 | humoral immune response |
2. P | GO:0042127 | regulation of cell population proliferation |
2. P | GO:0071866 | negative regulation of apoptotic process in bone marrow cell |
2. P | GO:0030301 | cholesterol transport |
2. P | GO:0005615 | extracellular space |
2. P | GO:0005133 | interferon-gamma receptor binding |
2. P | GO:0010753 | positive regulation of cGMP-mediated signaling |
2. P | GO:0016239 | positive regulation of macroautophagy |
2. P | GO:0002719 | negative regulation of cytokine production involved in immune response |
2. P | GO:0046676 | negative regulation of insulin secretion |
2. P | GO:1903816 | positive regulation of collecting lymphatic vessel constriction |
2. P | GO:0030354 | melanin-concentrating hormone activity |
2. P | GO:0030300 | regulation of intestinal cholesterol absorption |
2. P | GO:0010460 | positive regulation of heart rate |
2. P | GO:0005136 | interleukin-4 receptor binding |
2. P | GO:0008217 | regulation of blood pressure |
2. P | GO:0001878 | response to yeast |
2. P | GO:0007586 | digestion |
2. P | GO:0097647 | amylin receptor signaling pathway |
2. P | GO:2000253 | positive regulation of feeding behavior |
2. P | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep |
2. P | GO:0042157 | lipoprotein metabolic process |
2. P | GO:0043025 | neuronal cell body |
2. P | GO:2000987 | positive regulation of behavioral fear response |
2. P | GO:0008542 | visual learning |
2. P | GO:0009395 | phospholipid catabolic process |
2. P | GO:0071677 | positive regulation of mononuclear cell migration |
2. P | GO:0060348 | bone development |
2. P | GO:0097160 | polychlorinated biphenyl binding |
2. P | GO:1902807 | negative regulation of cell cycle G1/S phase transition |
2. P | GO:0035792 | host cell postsynaptic membrane |
2. P | GO:0031769 | glucagon receptor binding |
2. P | GO:0071855 | neuropeptide receptor binding |
2. P | GO:0006355 | regulation of transcription, DNA-templated |
2. P | GO:0060695 | negative regulation of cholesterol transporter activity |
2. P | GO:0048261 | negative regulation of receptor-mediated endocytosis |
2. P | GO:0031766 | type 3 galanin receptor binding |
2. P | GO:1904022 | positive regulation of G protein-coupled receptor internalization |
2. P | GO:0043627 | response to estrogen |
2. P | GO:0006656 | phosphatidylcholine biosynthetic process |
2. P | GO:0033574 | response to testosterone |
2. P | GO:0019732 | antifungal humoral response |
2. P | GO:0032100 | positive regulation of appetite |
2. P | GO:0009408 | response to heat |
2. P | GO:0030296 | protein tyrosine kinase activator activity |
2. P | GO:0090398 | cellular senescence |
2. P | GO:0031210 | phosphatidylcholine binding |
2. P | GO:0031409 | pigment binding |
2. P | GO:0031763 | galanin receptor binding |
2. P | GO:0034369 | plasma lipoprotein particle remodeling |
2. P | GO:0034380 | high-density lipoprotein particle assembly |
2. P | GO:0051428 | peptide hormone receptor binding |
2. P | GO:0002677 | negative regulation of chronic inflammatory response |
2. P | GO:0016004 | phospholipase activator activity |
2. P | GO:0030425 | dendrite |
2. P | GO:0005634 | nucleus |
2. P | GO:0031012 | extracellular matrix |
2. P | GO:0051006 | positive regulation of lipoprotein lipase activity |
2. P | GO:1900158 | negative regulation of bone mineralization involved in bone maturation |
2. P | GO:0097746 | blood vessel diameter maintenance |
2. P | GO:0034695 | response to prostaglandin E |
2. P | GO:0010629 | negative regulation of gene expression |
2. P | GO:0043203 | axon hillock |
2. P | GO:0003418 | growth plate cartilage chondrocyte differentiation |
2. P | GO:0016042 | lipid catabolic process |
2. P | GO:0010987 | negative regulation of high-density lipoprotein particle clearance |
2. P | GO:0006952 | defense response |
2. P | GO:0044616 | modulation of relaxation of muscle in another organism |
2. P | GO:0001764 | neuron migration |
2. P | GO:0030971 | receptor tyrosine kinase binding |
2. P | GO:0030157 | pancreatic juice secretion |
2. P | GO:0042632 | cholesterol homeostasis |
2. P | GO:0043434 | response to peptide hormone |
2. P | GO:0044849 | estrous cycle |
2. P | GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance |
2. P | GO:0043330 | response to exogenous dsRNA |
2. P | GO:0031877 | somatostatin receptor binding |
2. P | GO:0042976 | activation of Janus kinase activity |
2. P | GO:0032736 | positive regulation of interleukin-13 production |
2. P | GO:0035177 | larval foraging behavior |
2. P | GO:0042493 | |
2. P | GO:0005791 | rough endoplasmic reticulum |
2. P | GO:0014049 | positive regulation of glutamate secretion |
2. P | GO:0098556 | cytoplasmic side of rough endoplasmic reticulum membrane |
2. P | GO:0019933 | cAMP-mediated signaling |
2. P | GO:1904179 | positive regulation of adipose tissue development |
2. P | GO:0034375 | high-density lipoprotein particle remodeling |
2. P | GO:0051965 | positive regulation of synapse assembly |
2. P | GO:0035814 | negative regulation of renal sodium excretion |
2. P | GO:0010633 | negative regulation of epithelial cell migration |
2. P | GO:0032691 | negative regulation of interleukin-1 beta production |
2. P | GO:0007563 | regulation of eclosion |
2. P | GO:0030133 | transport vesicle |
2. P | GO:0045944 | positive regulation of transcription by RNA polymerase II |
2. P | GO:0042304 | regulation of fatty acid biosynthetic process |
2. P | GO:0045725 | positive regulation of glycogen biosynthetic process |
2. P | GO:0050830 | defense response to Gram-positive bacterium |
2. P | GO:1903672 | positive regulation of sprouting angiogenesis |
2. P | GO:0040013 | negative regulation of locomotion |
2. P | GO:0005137 | interleukin-5 receptor binding |
2. P | GO:0030252 | growth hormone secretion |
2. P | GO:0010193 | response to ozone |
2. P | GO:0060183 | apelin receptor signaling pathway |
2. P | GO:0010737 | protein kinase A signaling |
2. P | GO:0033700 | phospholipid efflux |
2. P | GO:0048873 | homeostasis of number of cells within a tissue |
2. P | GO:0045475 | locomotor rhythm |
2. P | GO:0031710 | neuromedin B receptor binding |
2. P | GO:0060732 | positive regulation of inositol phosphate biosynthetic process |
2. P | GO:0050688 | regulation of defense response to virus |
2. P | GO:0001774 | microglial cell activation |
2. P | GO:0005126 | cytokine receptor binding |
2. P | GO:0034362 | low-density lipoprotein particle |
2. P | GO:0007204 | positive regulation of cytosolic calcium ion concentration |
2. P | GO:0046887 | positive regulation of hormone secretion |
2. P | GO:0045168 | cell-cell signaling involved in cell fate commitment |
2. P | GO:1990637 | response to prolactin |
2. P | GO:0030424 | axon |
2. P | GO:0031530 | gonadotropin-releasing hormone receptor binding |
2. P | GO:0007409 | axonogenesis |
2. P | GO:0045667 | regulation of osteoblast differentiation |
2. P | GO:0048545 | response to steroid hormone |
2. P | GO:2000986 | negative regulation of behavioral fear response |
2. P | GO:0002314 | germinal center B cell differentiation |
2. P | GO:0008628 | hormone-mediated apoptotic signaling pathway |
2. P | GO:0031716 | calcitonin receptor binding |
2. P | GO:0035821 | modulation of process of another organism |
2. P | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity |
2. P | GO:0008200 | ion channel inhibitor activity |
2. P | GO:0055123 | digestive system development |
2. P | GO:0018990 | ecdysis, chitin-based cuticle |
2. P | GO:0005132 | type I interferon receptor binding |
2. P | GO:0009612 | response to mechanical stimulus |
2. P | GO:0045792 | negative regulation of cell size |
2. P | GO:0005737 | cytoplasm |
2. P | GO:0033344 | cholesterol efflux |
2. P | GO:0050766 | positive regulation of phagocytosis |
2. P | GO:0032571 | response to vitamin K |
2. P | GO:0070378 | positive regulation of ERK5 cascade |
2. P | GO:0005504 | fatty acid binding |
2. P | GO:0043005 | neuron projection |
2. P | GO:0042594 | response to starvation |
2. P | GO:0060697 | positive regulation of phospholipid catabolic process |
2. P | GO:0036122 | BMP binding |
2. P | GO:0071878 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway |
2. P | GO:0051480 | regulation of cytosolic calcium ion concentration |
2. P | GO:0008203 | cholesterol metabolic process |
2. P | GO:0034364 | high-density lipoprotein particle |
2. P | GO:1900076 | regulation of cellular response to insulin stimulus |
2. P | GO:0045671 | negative regulation of osteoclast differentiation |
2. P | GO:1990008 | neurosecretory vesicle |
2. P | GO:0032714 | negative regulation of interleukin-5 production |
2. P | GO:0031836 | neuromedin K receptor binding |
2. P | GO:0007631 | feeding behavior |
2. P | GO:0042755 | eating behavior |
2. P | GO:0036343 | psychomotor behavior |
2. P | GO:0001649 | osteoblast differentiation |
2. P | GO:0033280 | response to vitamin D |
2. P | GO:0045087 | innate immune response |
2. P | GO:0097005 | adipokinetic hormone receptor binding |
2. P | GO:1902608 | positive regulation of large conductance calcium-activated potassium channel activity |
2. P | GO:0008035 | high-density lipoprotein particle binding |
2. P | GO:0045823 | positive regulation of heart contraction |
2. P | GO:0071222 | cellular response to lipopolysaccharide |
2. P | GO:0090290 | positive regulation of osteoclast proliferation |
2. P | GO:0005135 | interleukin-3 receptor binding |
2. P | GO:0009416 | response to light stimulus |
2. P | GO:2000352 | negative regulation of endothelial cell apoptotic process |
2. P | GO:0042100 | B cell proliferation |
2. P | GO:0033594 | response to hydroxyisoflavone |
2. P | GO:0045717 | negative regulation of fatty acid biosynthetic process |
2. P | GO:1900223 | positive regulation of amyloid-beta clearance |
2. P | GO:0030500 | regulation of bone mineralization |
2. P | GO:2000404 | regulation of T cell migration |
2. P | GO:0051901 | positive regulation of mitochondrial depolarization |
2. P | GO:0050821 | protein stabilization |
2. P | GO:0007610 | behavior |
2. P | GO:0004966 | galanin receptor activity |
2. P | GO:0009967 | positive regulation of signal transduction |
2. P | GO:0002286 | T cell activation involved in immune response |
2. P | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway |
2. P | GO:1990834 | response to odorant |
2. P | GO:1900738 | positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway |
2. P | GO:0110150 | negative regulation of biomineralization |
2. P | GO:0000187 | obsolete activation of MAPK activity |
2. P | GO:0001984 | artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure |
2. P | GO:0019834 | phospholipase A2 inhibitor activity |
2. P | GO:0019233 | sensory perception of pain |
2. P | GO:0007168 | receptor guanylyl cyclase signaling pathway |
2. P | GO:0008285 | negative regulation of cell population proliferation |
2. P | GO:0051384 | response to glucocorticoid |
2. P | GO:0031837 | substance K receptor binding |
2. P | GO:1905665 | positive regulation of calcium ion import across plasma membrane |
2. P | GO:0045968 | negative regulation of juvenile hormone biosynthetic process |
2. P | GO:0070328 | triglyceride homeostasis |
2. P | GO:0021984 | adenohypophysis development |
2. P | GO:0043400 | cortisol secretion |
2. P | GO:0060455 | negative regulation of gastric acid secretion |
2. P | GO:0007629 | flight behavior |
2. P | GO:2000424 | positive regulation of eosinophil chemotaxis |
2. P | GO:0048260 | positive regulation of receptor-mediated endocytosis |
2. P | GO:0046340 | diacylglycerol catabolic process |
2. P | GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand |
2. P | GO:1903999 | negative regulation of eating behavior |
2. P | GO:0031768 | ghrelin receptor binding |
2. P | GO:0045833 | negative regulation of lipid metabolic process |
2. P | GO:0031640 | killing of cells of another organism |
2. P | GO:0031045 | dense core granule |
2. P | GO:0043204 | perikaryon |
2. P | GO:0042311 | vasodilation |
2. P | GO:2000320 | negative regulation of T-helper 17 cell differentiation |
2. P | GO:0050776 | regulation of immune response |
2. P | GO:0061470 | T follicular helper cell differentiation |
2. P | GO:0031788 | motilin receptor binding |
2. P | GO:0043679 | axon terminus |
2. P | GO:0090729 | toxin activity |
2. P | GO:0030154 | cell differentiation |
2. P | GO:0055062 | phosphate ion homeostasis |
2. P | GO:0032094 | response to food |
2. P | GO:0009411 | response to UV |
2. P | GO:0060452 | positive regulation of cardiac muscle contraction |
2. P | GO:0005798 | Golgi-associated vesicle |
2. P | GO:0031767 | gastric inhibitory polypeptide receptor binding |
2. P | GO:0032375 | negative regulation of cholesterol transport |
2. P | GO:0042113 | B cell activation |
2. P | GO:0046326 | positive regulation of glucose import |
2. P | GO:0016021 | integral component of membrane |
2. P | GO:0008284 | positive regulation of cell population proliferation |
2. P | GO:0031773 | kisspeptin receptor binding |
2. P | GO:0031175 | neuron projection development |
2. P | GO:0001664 | G protein-coupled receptor binding |
2. P | GO:0046888 | negative regulation of hormone secretion |
2. P | GO:0001503 | ossification |
2. P | GO:0032696 | negative regulation of interleukin-13 production |
2. P | GO:0007186 | G protein-coupled receptor signaling pathway |
2. P | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response |
2. P | GO:0045582 | positive regulation of T cell differentiation |
2. P | GO:0002213 | defense response to insect |
2. P | GO:0048247 | lymphocyte chemotaxis |
2. P | GO:0062023 | collagen-containing extracellular matrix |
2. P | GO:0090274 | positive regulation of somatostatin secretion |
2. P | GO:0031960 | response to corticosteroid |
2. P | GO:0042742 | defense response to bacterium |
2. P | GO:0007562 | eclosion |
2. P | GO:0006182 | cGMP biosynthetic process |
2. P | GO:0031214 | biomineral tissue development |
2. P | GO:0010996 | response to auditory stimulus |
2. P | GO:0042599 | lamellar body |
2. P | GO:0004859 | phospholipase inhibitor activity |
2. P | GO:0051005 | negative regulation of lipoprotein lipase activity |
2. P | GO:0031844 | type 4 neuropeptide Y receptor binding |
2. P | GO:0090280 | positive regulation of calcium ion import |
2. P | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus |
2. P | GO:0010459 | negative regulation of heart rate |
2. P | GO:2000553 | positive regulation of T-helper 2 cell cytokine production |
2. P | GO:0034370 | triglyceride-rich lipoprotein particle remodeling |
2. P | GO:0001937 | negative regulation of endothelial cell proliferation |
2. P | GO:0034361 | very-low-density lipoprotein particle |
2. P | GO:0046697 | decidualization |
2. P | GO:0050829 | defense response to Gram-negative bacterium |
2. P | GO:0008047 | enzyme activator activity |
2. P | GO:0120058 | positive regulation of small intestinal transit |
2. P | GO:0007605 | sensory perception of sound |
2. P | GO:0019934 | cGMP-mediated signaling |
2. P | GO:0001696 | gastric acid secretion |
2. P | GO:0005576 | extracellular region |
2. P | GO:0043691 | reverse cholesterol transport |
2. P | GO:0002026 | regulation of the force of heart contraction |
2. P | GO:0034379 | very-low-density lipoprotein particle assembly |
2. P | GO:0006953 | acute-phase response |
2. P | GO:0042756 | drinking behavior |
2. P | GO:0005186 | pheromone activity |
2. P | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation |
2. P | GO:1904346 | positive regulation of gastric mucosal blood circulation |
2. P | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction |
2. P | GO:0007268 | chemical synaptic transmission |
2. P | GO:0099170 | postsynaptic modulation of chemical synaptic transmission |
2. P | GO:0003085 | negative regulation of systemic arterial blood pressure |
2. P | GO:0006954 | inflammatory response |
2. P | GO:0042600 | egg chorion |
2. P | GO:0007267 | cell-cell signaling |
2. P | GO:1904349 | positive regulation of small intestine smooth muscle contraction |
2. P | GO:0002227 | innate immune response in mucosa |
2. P | GO:0060392 | negative regulation of SMAD protein signal transduction |
2. P | GO:0071803 | positive regulation of podosome assembly |
2. P | GO:0051430 | corticotropin-releasing hormone receptor 1 binding |
2. P | GO:0032903 | regulation of nerve growth factor production |
2. P | GO:0140301 | pollen-stigma interaction |
2. P | GO:0018158 | protein oxidation |
2. P | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide |
2. P | GO:0002230 | positive regulation of defense response to virus by host |
2. P | GO:0007588 | excretion |
2. P | GO:0035176 | social behavior |
2. P | GO:0010960 | magnesium ion homeostasis |
2. P | GO:0071859 | neuropeptide F receptor binding |
2. P | GO:0043657 | host cell |
2. P | GO:0007202 | activation of phospholipase C activity |
2. P | GO:0005886 | plasma membrane |
2. P | GO:0043117 | positive regulation of vascular permeability |
2. P | GO:0008147 | structural constituent of bone |
2. P | GO:0030890 | positive regulation of B cell proliferation |
2. P | GO:0042325 | regulation of phosphorylation |
2. P | GO:0005179 | hormone activity |
2. P | GO:0001836 | release of cytochrome c from mitochondria |
2. P | GO:0006962 | male-specific antibacterial humoral response |
2. P | GO:0010890 | positive regulation of sequestering of triglyceride |
2. P | GO:0031145 | anaphase-promoting complex-dependent catabolic process |
2. P | GO:1901562 | response to paraquat |
2. P | GO:1904014 | response to serotonin |
2. P | GO:0030103 | vasopressin secretion |
2. P | GO:0007217 | tachykinin receptor signaling pathway |
2. P | GO:0033686 | positive regulation of luteinizing hormone secretion |
2. P | GO:0034384 | high-density lipoprotein particle clearance |
2. P | GO:1902093 | positive regulation of flagellated sperm motility |
2. P | GO:0005125 | cytokine activity |
2. P | GO:1904058 | positive regulation of sensory perception of pain |
2. P | GO:0035738 | envenomation resulting in modulation of process in another organism |
2. P | GO:0043274 | phospholipase binding |
2. P | GO:0002674 | negative regulation of acute inflammatory response |
2. P | GO:0030430 | host cell cytoplasm |
2. P | GO:0060124 | positive regulation of growth hormone secretion |
2. P | GO:0016358 | dendrite development |
2. P | GO:0031841 | neuropeptide Y receptor binding |
2. P | GO:0044179 | hemolysis in another organism |
2. P | GO:0042595 | behavioral response to starvation |
2. P | GO:0042151 | nematocyst |
2. P | GO:0034021 | response to silicon dioxide |
2. P | GO:0010447 | response to acidic pH |
2. P | GO:0043200 | response to amino acid |
2. P | GO:0034645 | cellular macromolecule biosynthetic process |
2. P | GO:0045776 | negative regulation of blood pressure |
2. P | GO:0008255 | ecdysis-triggering hormone activity |
2. P | GO:0034374 | low-density lipoprotein particle remodeling |
2. P | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness |
2. P | GO:0034366 | spherical high-density lipoprotein particle |
2. P | GO:0007275 | multicellular organism development |
2. P | GO:0051447 | negative regulation of meiotic cell cycle |
2. P | GO:0045471 | response to ethanol |
2. P | GO:0070314 | G1 to G0 transition |
2. P | GO:2000843 | regulation of testosterone secretion |
2. P | GO:1901741 | positive regulation of myoblast fusion |
2. P | GO:1903012 | positive regulation of bone development |
2. P | GO:0045348 | positive regulation of MHC class II biosynthetic process |
2. P | GO:0030183 | B cell differentiation |
2. P | GO:1902436 | negative regulation of male mating behavior |
2. P | GO:0003677 | DNA binding |
2. P | GO:0045906 | negative regulation of vasoconstriction |
2. P | GO:0009617 | response to bacterium |
2. P | GO:0008031 | eclosion hormone activity |
2. P | GO:0098794 | postsynapse |
2. P | GO:0050806 | positive regulation of synaptic transmission |
2. P | GO:2000252 | negative regulation of feeding behavior |
2. P | GO:0032504 | multicellular organism reproduction |
2. P | GO:0060079 | excitatory postsynaptic potential |
2. P | GO:0042102 | positive regulation of T cell proliferation |
2. P | GO:0008083 | growth factor activity |
2. P | GO:1901857 | positive regulation of cellular respiration |
2. P | GO:0040010 | positive regulation of growth rate |
2. P | GO:0010183 | pollen tube guidance |
2. P | GO:0021987 | cerebral cortex development |
2. P | GO:0021954 | central nervous system neuron development |
2. P | GO:0016608 | growth hormone-releasing hormone activity |
2. P | GO:0042627 | chylomicron |
2. P | GO:0042025 | host cell nucleus |
2. P | GO:0005739 | mitochondrion |
2. P | GO:0003084 | positive regulation of systemic arterial blood pressure |
2. P | GO:0031857 | type 1 parathyroid hormone receptor binding |
2. P | GO:0055102 | lipase inhibitor activity |
2. P | GO:0045986 | negative regulation of smooth muscle contraction |
2. P | GO:0060547 | negative regulation of necrotic cell death |
2. P | GO:0008049 | male courtship behavior |
2. P | GO:0033612 | receptor serine/threonine kinase binding |
2. P | GO:0090187 | positive regulation of pancreatic juice secretion |
2. P | GO:1904000 | positive regulation of eating behavior |
2. P | GO:1901218 | negative regulation of holin activity |
2. P | GO:0034382 | chylomicron remnant clearance |
2. P | GO:0045779 | negative regulation of bone resorption |
2. P | GO:0051930 | regulation of sensory perception of pain |
2. P | GO:0031667 | response to nutrient levels |
2. P | GO:0051427 | hormone receptor binding |
2. P | GO:0031765 | type 2 galanin receptor binding |
2. P | GO:0018206 | peptidyl-methionine modification |
2. P | GO:0048706 | embryonic skeletal system development |
2. P | GO:0034363 | intermediate-density lipoprotein particle |
2. P | GO:0050672 | negative regulation of lymphocyte proliferation |
2. P | GO:0038002 | endocrine signaling |
2. P | GO:0046848 | hydroxyapatite binding |
2. P | GO:0007565 | female pregnancy |
2. P | GO:0035864 | response to potassium ion |
2. P | GO:0032496 | response to lipopolysaccharide |
2. P | GO:0032720 | negative regulation of tumor necrosis factor production |
2. P | GO:2001223 | negative regulation of neuron migration |
2. P | GO:0034190 | apolipoprotein receptor binding |
2. P | GO:0070094 | positive regulation of glucagon secretion |
2. P | GO:0007218 | neuropeptide signaling pathway |
2. P | GO:0048572 | short-day photoperiodism |
2. P | GO:0032733 | positive regulation of interleukin-10 production |
2. P | GO:0008345 | larval locomotory behavior |
2. P | GO:0031878 | type 1 somatostatin receptor binding |
2. P | GO:0044165 | host cell endoplasmic reticulum |
2. P | GO:0009725 | response to hormone |
2. P | GO:0031843 | type 2 neuropeptide Y receptor binding |
2. P | GO:0030141 | secretory granule |
2. P | GO:0007190 | activation of adenylate cyclase activity |
2. P | GO:1903640 | negative regulation of gastrin-induced gastric acid secretion |
2. P | GO:0050996 | positive regulation of lipid catabolic process |
2. P | GO:0043194 | axon initial segment |
2. P | GO:0043278 | response to morphine |
2. P | GO:0048265 | response to pain |
2. P | GO:0051431 | corticotropin-releasing hormone receptor 2 binding |
2. P | GO:0043066 | negative regulation of apoptotic process |
2. P | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein |
2. P | GO:0045518 | interleukin-22 receptor binding |
2. P | GO:0007165 | signal transduction |
2. P | GO:0090277 | positive regulation of peptide hormone secretion |
2. P | GO:0031856 | parathyroid hormone receptor binding |
2. P | GO:0043306 | positive regulation of mast cell degranulation |
2. P | GO:0016020 | membrane |
2. P | GO:0032096 | negative regulation of response to food |
2. P | GO:0043031 | negative regulation of macrophage activation |
2. P | GO:0006955 | immune response |
2. P | GO:0000003 | reproduction |
2. P | GO:0008343 | adult feeding behavior |
2. P | GO:0050965 | detection of temperature stimulus involved in sensory perception of pain |
2. P | GO:0015485 | cholesterol binding |
2. P | GO:0010873 | positive regulation of cholesterol esterification |
2. P | GO:0045777 | positive regulation of blood pressure |
2. P | GO:0051461 | positive regulation of corticotropin secretion |
2. P | GO:0034199 | activation of protein kinase A activity |
2. P | GO:0043950 | positive regulation of cAMP-mediated signaling |
2. P | GO:0070351 | negative regulation of white fat cell proliferation |
2. P | GO:0006874 | cellular calcium ion homeostasis |
2. P | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep |
2. P | GO:0045064 | T-helper 2 cell differentiation |
2. P | GO:0022404 | molting cycle process |
2. P | GO:0098992 | neuronal dense core vesicle |
2. P | GO:0043195 | terminal bouton |
2. P | GO:0030298 | receptor signaling protein tyrosine kinase activator activity |
2. P | GO:0032095 | regulation of response to food |
2. P | GO:1905564 | positive regulation of vascular endothelial cell proliferation |
2. P | GO:0060575 | intestinal epithelial cell differentiation |
2. P | GO:0045596 | negative regulation of cell differentiation |
2. P | GO:0006972 | hyperosmotic response |
2. P | GO:0051966 | regulation of synaptic transmission, glutamatergic |
2. P | GO:0060976 | coronary vasculature development |
2. P | GO:0006869 | lipid transport |
2. P | GO:0008613 | diuretic hormone activity |
2. P | GO:0048018 | receptor ligand activity |
2. P | GO:0010518 | positive regulation of phospholipase activity |
2. P | GO:0008154 | actin polymerization or depolymerization |
2. P | GO:0071858 | corazonin receptor binding |
2. P | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling |
2. P | GO:0030250 | guanylate cyclase activator activity |
2. P | GO:0099175 | regulation of postsynapse organization |
2. P | GO:0120162 | positive regulation of cold-induced thermogenesis |
2. P | GO:0031764 | type 1 galanin receptor binding |
2. P | GO:0035483 | gastric emptying |
2. P | GO:0043207 | response to external biotic stimulus |
2. P | GO:0002323 | natural killer cell activation involved in immune response |
2. P | GO:0003254 | regulation of membrane depolarization |
2. P | GO:0032098 | regulation of appetite |
2. P | GO:0071774 | response to fibroblast growth factor |
2. P | GO:0046659 | digestive hormone activity |
2. P | GO:0051464 | positive regulation of cortisol secretion |
2. P | GO:0010828 | positive regulation of glucose transmembrane transport |
2. P | GO:0005102 | signaling receptor binding |
2. P | GO:0043196 | varicosity |
2. P | GO:0034774 | secretory granule lumen |
2. P | GO:0003419 | growth plate cartilage chondrocyte proliferation |
2. P | GO:0010898 | positive regulation of triglyceride catabolic process |
2. P | GO:1900194 | negative regulation of oocyte maturation |
2. P | GO:0032868 | response to insulin |
2. P | GO:0050728 | negative regulation of inflammatory response |
2. P | GO:0005184 | neuropeptide hormone activity |
2. P | GO:0042748 | circadian sleep/wake cycle, non-REM sleep |
2. P | GO:0019836 | hemolysis by symbiont of host erythrocytes |
2. P | GO:0030536 | larval feeding behavior |
2. P | GO:0032715 | negative regulation of interleukin-6 production |
2. P | GO:0034447 | very-low-density lipoprotein particle clearance |
2. P | GO:0031296 | B cell costimulation |
2. P | GO:0032757 | positive regulation of interleukin-8 production |
2. P | GO:0048304 | positive regulation of isotype switching to IgG isotypes |
2. P | GO:0051795 | positive regulation of timing of catagen |
2. P | GO:0010989 | negative regulation of low-density lipoprotein particle clearance |
2. P | GO:0022414 | reproductive process |
2. P | GO:0044539 | long-chain fatty acid import into cell |
2. P | GO:0032967 | positive regulation of collagen biosynthetic process |
2. P | GO:0040018 | positive regulation of multicellular organism growth |
2. P | GO:0071864 | positive regulation of cell proliferation in bone marrow |
2. P | GO:0050832 | defense response to fungus |
2. P | GO:2000354 | regulation of ovarian follicle development |
2. P | GO:0048295 | positive regulation of isotype switching to IgE isotypes |
2. P | GO:0002639 | positive regulation of immunoglobulin production |
2. P | GO:2000854 | positive regulation of corticosterone secretion |
2. P | GO:0007589 | body fluid secretion |
2. P | GO:0019835 | cytolysis |
2. P | GO:0032099 | negative regulation of appetite |
2. P | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep |
2. P | GO:0071107 | response to parathyroid hormone |
2. P | GO:0070253 | somatostatin secretion |
2. P | GO:0033087 | negative regulation of immature T cell proliferation |
2. P | GO:0031943 | regulation of glucocorticoid metabolic process |
2. P | GO:0031770 | growth hormone-releasing hormone receptor binding |
2. P | GO:0051969 | regulation of transmission of nerve impulse |
2. P | GO:0005829 | cytosol |
2. P | GO:0047485 | protein N-terminus binding |
2. P | GO:0046811 | histone deacetylase inhibitor activity |
2. P | GO:0046872 | metal ion binding |
2. P | GO:0045202 | synapse |
2. P | GO:0051673 | membrane disruption in another organism |
2. P | GO:0031700 | adrenomedullin receptor binding |
2. P | GO:0070653 | high-density lipoprotein particle receptor binding |
2. P | GO:0030501 | positive regulation of bone mineralization |
2. P | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
2. P | GO:0032024 | positive regulation of insulin secretion |
2. P | GO:0071351 | cellular response to interleukin-18 |
2. P | GO:0010897 | negative regulation of triglyceride catabolic process |
2. P | GO:1903660 | negative regulation of complement-dependent cytotoxicity |
Homologs
1. PB indicates the homologs that are found by both PROST and BLAST.
2. P indicates homologs that are only found by PROST.
3. B indicates homologs that are only found by BLAST.
Source | Homolog | Description | FATCAT p-val | PROST Evalue | BLAST Evalue |
---|---|---|---|---|---|
1. PB | A0A1B0GTC6 | Uncharacterized protein C3orf85 | 0 | 5.97e-105 | 2.77e-63 |
2. P | D2Y240 | U3-theraphotoxin-Hhn1a 1 | 1.02e-01 | 7.19e-03 | NA |
2. P | P67792 | Cecropin-B | 1.59e-03 | 6.10e-07 | NA |
2. P | P02652 | Apolipoprotein A-II | 2.70e-04 | 7.10e-09 | NA |
2. P | P51917 | Progonadoliberin-3 | 8.55e-03 | 4.85e-07 | NA |
2. P | P01563 | Interferon alpha-2 | 6.58e-03 | 2.36e-02 | NA |
2. P | Q7T3K8 | Dermaseptin-S7 | 9.05e-04 | 4.02e-04 | NA |
2. P | Q2V371 | Defensin-like protein 24 | 1.25e-01 | 4.57e-02 | NA |
2. P | D2Y244 | U3-theraphotoxin-Hhn1j | 1.21e-01 | 5.79e-03 | NA |
2. P | Q9DD49 | Progonadoliberin-3 | 1.58e-02 | 2.44e-09 | NA |
2. P | Q96QR1 | Secretoglobin family 3A member 1 | 5.08e-03 | 3.17e-02 | NA |
2. P | Q6UWK7 | Protein GPR15L | 2.20e-04 | 2.53e-04 | NA |
2. P | O18493 | Clavanin-C | 6.50e-05 | 4.48e-04 | NA |
2. P | P04812 | Seminal vesicle secretory protein 5 | 1.05e-01 | 1.29e-03 | NA |
2. P | A0A0D9S1R4 | Apolipoprotein C-IV | 1.28e-03 | 1.11e-08 | NA |
2. P | J3QPP8 | ALK and LTK ligand 1 | 1.11e-01 | 2.33e-05 | NA |
2. P | Q58T46 | Maximins 3/H14 | 8.15e-04 | 6.84e-03 | NA |
2. P | P86187 | Raniseptin-5 | 9.20e-05 | 9.08e-03 | NA |
2. P | D0P1A8 | RxLR effector protein Avrblb2 | 2.00e-02 | 3.22e-07 | NA |
2. P | F1T150 | Esculentin-1ISb | 4.79e-03 | 8.83e-04 | NA |
2. P | A0A330KUG5 | U-actitoxin-Oulsp2 | 4.59e-02 | 1.76e-02 | NA |
2. P | P25331 | Eclosion hormone | 7.49e-02 | 1.63e-02 | NA |
2. P | P04560 | Prepro-urotensin II-alpha | 5.95e-02 | 4.75e-02 | NA |
2. P | P54615 | Osteocalcin-related protein | 1.82e-02 | 2.67e-09 | NA |
2. P | B3EWG0 | Red pigment-concentrating hormone | 2.08e-03 | 1.78e-07 | NA |
2. P | P02654 | Apolipoprotein C-I | 9.47e-04 | 3.55e-05 | NA |
2. P | W4VS46 | Toxin ICK-10 | 6.52e-04 | 4.94e-02 | NA |
2. P | Q9IAU2 | Trp-8 progonadoliberin | 1.19e-02 | 1.58e-09 | NA |
2. P | P0CV59 | Secreted RxLR effector protein 143 | 6.75e-02 | 7.59e-05 | NA |
2. P | F5CPE8 | Natriuretic peptide | 2.19e-01 | 1.38e-04 | NA |
2. P | Q8NHW6 | Otospiralin | 3.08e-02 | 1.91e-11 | NA |
2. P | B1P1I3 | U31-theraphotoxin-Cg1a | 4.77e-03 | 9.96e-05 | NA |
2. P | P0DML5 | Apolipoprotein C-IV | 9.13e-04 | 3.39e-04 | NA |
2. P | P0DM83 | Apolipoprotein C-I | 8.25e-04 | 1.14e-05 | NA |
2. P | P28902 | Guanylin | 5.87e-02 | 2.63e-04 | NA |
2. P | P12968 | Islet amyloid polypeptide | 1.80e-02 | 4.95e-04 | NA |
2. P | P0DTG3 | Apolipoprotein C-I | 1.18e-03 | 3.11e-05 | NA |
2. P | P0DPH0 | Apolipoprotein C-I | 6.90e-04 | 1.75e-04 | NA |
2. P | P70664 | Guanylin | 7.95e-02 | 1.47e-04 | NA |
2. P | P04092 | Glucagon-2 | 3.78e-03 | 1.73e-06 | NA |
2. P | Q54TK1 | Uncharacterized protein DDB_G0281701 | 3.15e-05 | 2.46e-02 | NA |
2. P | Q8N729 | Neuropeptide W | 2.67e-02 | 1.91e-02 | NA |
2. P | Q9I8P2 | Peptide YY-A | 3.58e-03 | 3.65e-07 | NA |
2. P | P0DJG2 | Apolipoprotein A-II | 1.61e-04 | 7.10e-09 | NA |
2. P | B9TQX4 | Unique cartilage matrix-associated protein | 1.97e-03 | 8.35e-06 | NA |
2. P | M1E1F0 | U2-sicaritoxin-Sdo1a | 9.62e-03 | 2.40e-02 | NA |
2. P | Q9BDJ6 | Appetite-regulating hormone | 1.51e-02 | 9.43e-07 | NA |
2. P | P04204 | Exendin-2-long | 3.28e-03 | 3.21e-04 | NA |
2. P | P69108 | Progonadoliberin-3 | 2.77e-02 | 3.34e-06 | NA |
2. P | Q7YS71 | Interleukin-4 | 3.33e-03 | 5.64e-03 | NA |
2. P | Q8K559 | Otospiralin | 4.75e-02 | 1.56e-10 | NA |
2. P | Q1ELU9 | M-zodatoxin-Lt5a | 3.53e-04 | 5.46e-03 | NA |
2. P | P02659 | Apovitellenin-1 | 1.70e-03 | 3.40e-11 | NA |
2. P | O93222 | Plasticin-A1 | 3.31e-03 | 4.68e-02 | NA |
2. P | Q9BP64 | Conotoxin PnMSGL-01 | 7.10e-02 | 1.30e-02 | NA |
2. P | C0HKT1 | Neuropeptide CCHamide-2 | 6.24e-03 | 7.45e-05 | NA |
2. P | Q8QFQ3 | Ranatuerin-2Pa | 9.29e-04 | 4.98e-02 | NA |
2. P | P43306 | Progonadoliberin-2 | 6.28e-02 | 1.06e-09 | NA |
2. P | W2P2K7 | Secreted RxLR effector protein 3 | 1.52e-01 | 1.07e-03 | NA |
2. P | Q8AYR6 | C-type natriuretic peptide 1 | 1.72e-02 | 3.46e-02 | NA |
2. P | H6S3X4 | Secreted RxLR effector protein 18 | 3.79e-02 | 6.50e-12 | NA |
2. P | Q30KP9 | Beta-defensin 135 | 6.83e-02 | 4.57e-02 | NA |
2. P | Q90ZY0 | Pleurocidin | 1.91e-03 | 1.51e-02 | NA |
2. P | P0DSK7 | U-myrmeciitoxin(01)-Mg9a | 1.16e-01 | 6.05e-05 | NA |
2. P | D0N0N6 | RxLR effector protein SFI2 | 3.93e-03 | 5.88e-03 | NA |
2. P | P22466 | Galanin peptides | 3.12e-02 | 6.23e-07 | NA |
2. P | P0CI14 | Augerpeptide Hhe9a | 5.12e-02 | 4.75e-02 | NA |
2. P | P0DJ02 | Peptide Hp1090 | 2.05e-04 | 2.81e-03 | NA |
2. P | Q76CA0 | Delta-stichotoxin-Sgt3a | 8.30e-03 | 2.06e-02 | NA |
2. P | P0CH45 | Putative N.vectensis toxin 1 9 | 1.59e-02 | 3.76e-03 | NA |
2. P | Q07892 | Eclosion hormone | 2.59e-02 | 3.88e-04 | NA |
2. P | Q9YGH4 | Somatostatin-2 | 8.46e-04 | 5.41e-03 | NA |
2. P | A0A1L2F565 | Parathyroid hormone 4 | 8.49e-04 | 6.11e-05 | NA |
2. P | Q29B55 | Neuropeptide F | 6.88e-04 | 2.07e-07 | NA |
2. P | P31862 | Bowman-Birk type wound-induced proteinase inhibitor WIP1 | 3.67e-03 | 6.14e-03 | NA |
2. P | O93454 | Plasticin-DA1 | 6.19e-04 | 2.99e-03 | NA |
2. P | Q7M742 | Secretoglobin family 1C member 1 | 7.27e-04 | 1.97e-06 | NA |
2. P | P06740 | Interleukin-3 | 2.30e-03 | 3.37e-06 | NA |
2. P | B3IWF8 | Calcitonin receptor-stimulating peptide 2 | 6.88e-04 | 5.92e-04 | NA |
2. P | P0C8E3 | Conantokin-P | 1.39e-04 | 2.93e-04 | NA |
2. P | K9N796 | Non-structural protein ORF3 | NA | 3.66e-02 | NA |
2. P | Q800I8 | C-type natriuretic peptide 3 | 6.59e-04 | 2.21e-03 | NA |
2. P | P19872 | Adipokinetic prohormone type 3 | 3.61e-04 | 2.03e-10 | NA |
2. P | B4G532 | Protein Turandot X | 1.03e-03 | 2.93e-04 | NA |
2. P | Q6UX46 | ALK and LTK ligand 2 | 1.19e-02 | 2.38e-02 | NA |
2. P | Q766Y7 | Calcitonin receptor-stimulating peptide 2 | 1.55e-03 | 6.02e-06 | NA |
2. P | P0DN57 | Teretoxin Tan9.6 | 6.16e-03 | 8.02e-03 | NA |
2. P | B4II58 | Protein Turandot A1/2 | 4.54e-03 | 1.64e-02 | NA |
2. P | P06881 | Calcitonin gene-related peptide 1 | 1.78e-03 | 5.64e-03 | NA |
2. P | Q8QFQ4 | Ranatuerin-2P | 1.52e-04 | 1.38e-02 | NA |
2. P | E0W5H5 | RxLR effector protein Avh262 | 9.77e-04 | 3.71e-04 | NA |
2. P | O18492 | Clavanin-E | 5.43e-05 | 5.40e-05 | NA |
2. P | P86336 | Apolipoprotein C-I, acidic form | 1.35e-03 | 5.97e-07 | NA |
2. P | Q9FRF9 | Phytosulfokines 3 | 1.50e-02 | 2.99e-05 | NA |
2. P | A0A193H329 | Cruzioseptin-8 | 1.40e-04 | 1.08e-05 | NA |
2. P | P0CG46 | Conantokin-Br | 1.77e-02 | 5.66e-04 | NA |
2. P | P79886 | Apovitellenin-1 | 2.01e-03 | 1.74e-14 | NA |
2. P | P49127 | Delta-hormotoxin-Cpt1a | 9.74e-04 | 1.45e-02 | NA |
2. P | P0DUT6 | U-limacoditoxin(59)-Dv128 | NA | 2.23e-02 | NA |
2. P | Q19569 | Neuropeptide-like protein 7 | 1.37e-02 | 3.55e-05 | NA |
2. P | F1T154 | Brevinin-2ISb | 3.47e-04 | 7.20e-04 | NA |
2. P | Q1ELU2 | M-zodatoxin-Lt3b | 3.28e-03 | 2.58e-04 | NA |
2. P | Q08535 | Secretin | 3.58e-03 | 1.18e-03 | NA |
2. P | P56972 | Scorpine | 3.65e-02 | 1.27e-03 | NA |
2. P | Q5Y4W5 | U2-agatoxin-Ao1w | 1.80e-02 | 2.34e-02 | NA |
2. P | P0DPV4 | Kappa-scoloptoxin(04)-Ssd1b | 8.77e-03 | 8.50e-03 | NA |
2. P | P0DN40 | Apolipoprotein C-II | 1.99e-04 | 7.42e-09 | NA |
2. P | Q8IN44 | Protein Turandot A | 5.52e-03 | 1.55e-03 | NA |
2. P | P18313 | Sapecin | 1.07e-01 | 6.71e-04 | NA |
2. P | P48097 | Neuropeptide Y | 2.98e-02 | 7.94e-04 | NA |
2. P | P81490 | Dermaseptin-B6 | 4.08e-04 | 1.54e-06 | NA |
2. P | C6EVG1 | Exendin-4 | 1.14e-02 | 1.76e-06 | NA |
2. P | P49112 | Neutrophil cationic peptide 2 | 2.30e-01 | 2.95e-02 | NA |
2. P | A0A144LVL3 | Centrocin 2 | 9.44e-04 | 4.06e-02 | NA |
2. P | Q0GY44 | Potassium channel toxin Tdi-beta-KTx | 1.51e-02 | 1.04e-02 | NA |
2. P | Q0VBW8 | Neuromedin-S | 4.42e-03 | 2.05e-04 | NA |
2. P | P06913 | Uteroglobin | 1.28e-02 | 4.30e-05 | NA |
2. P | Q30KP5 | Beta-defensin 18 | 2.02e-02 | 3.60e-02 | NA |
2. P | Q8I6S3 | Tachykinin-1 | 1.08e-02 | 4.39e-05 | NA |
2. P | P0CV02 | Secreted RxLR effector protein 31 | 4.58e-03 | 3.23e-02 | NA |
2. P | G1FSB5 | RxLR effector protein Avh238 | 9.80e-03 | 2.45e-03 | NA |
2. P | Q1EN12 | Dermaseptin-S12 (Fragment) | 7.73e-04 | 1.47e-04 | NA |
2. P | P0CV37 | Secreted RxLR effector protein 93 | 1.36e-02 | 8.08e-03 | NA |
2. P | Q9WVA8 | Pro-FMRFamide-related neuropeptide FF | 1.04e-01 | 1.05e-03 | NA |
2. P | P84020 | Cecropin-C | 1.53e-03 | 4.28e-08 | NA |
2. P | Q8MMJ7 | Cytotoxic linear peptide IsCT | 5.31e-04 | 2.52e-02 | NA |
2. P | D2Y248 | U3-theraphotoxin-Hhn1a 5 | 3.88e-02 | 4.91e-02 | NA |
2. P | P07095 | Blood plasma apolipoprotein LAL1 | 2.69e-05 | 1.42e-08 | NA |
2. P | Q865X5 | Interleukin-4 | 3.30e-03 | 3.25e-02 | NA |
2. P | A0A348G5W0 | U-poneritoxin(01)-Om4a | 1.03e-03 | 5.50e-03 | NA |
2. P | Q4G0G5 | Secretoglobin family 2B member 2 | 3.40e-03 | 7.87e-08 | NA |
2. P | Q0N4U5 | Alpha/kappa-conotoxin-like pl14.3 | 4.29e-03 | 1.81e-02 | NA |
2. P | G3ETQ3 | Palustrin-2AJ1 | 4.66e-04 | 2.48e-02 | NA |
2. P | A7RMN1 | Toxin NvePTx1 | 1.48e-02 | 9.78e-05 | NA |
2. P | P84224 | Cecropin-C | 7.56e-04 | 4.10e-07 | NA |
2. P | P01168 | Somatostatin | 2.41e-03 | 1.49e-02 | NA |
2. P | Q90ZK5 | Dermaseptin-B8 | 2.17e-04 | 7.67e-04 | NA |
2. P | Q9DGK7 | Pro-neuropeptide Y | 9.42e-03 | 2.72e-03 | NA |
2. P | E7EKH3 | Brevinin-2SN1 | 1.21e-03 | 4.68e-02 | NA |
2. P | Q9BPE3 | Conotoxin TsMLCL-03 | 3.94e-04 | 3.61e-04 | NA |
2. P | P81488 | Dermaseptin-B9 | 9.14e-05 | 1.56e-05 | NA |
2. P | C0HKT4 | Diuretic hormone 41 | 5.84e-03 | 3.51e-04 | NA |
2. P | P07507 | Matrix Gla protein | 2.55e-02 | 3.20e-05 | NA |
2. P | Q2WCN6 | Pelophylaxin-3 | 4.19e-04 | 3.92e-06 | NA |
2. P | Q8K560 | Otospiralin | 2.37e-02 | 1.31e-08 | NA |
2. P | O46166 | U1-agatoxin-Ta1a | 1.80e-01 | 3.99e-03 | NA |
2. P | A0A172M473 | Secreted RxLR effector protein 29 | 1.61e-03 | 8.02e-03 | NA |
2. P | P0DJK0 | Sarafotoxin-i1 | 1.15e-01 | 4.72e-02 | NA |
2. P | P22000 | Serum amyloid A-2 protein | 5.12e-04 | 3.15e-02 | NA |
2. P | Q8MTX2 | Cytotoxic linear peptide IsCT2 | 4.60e-03 | 2.99e-03 | NA |
2. P | P47841 | Matrix Gla protein | 2.26e-02 | 4.56e-05 | NA |
2. P | G5BWH8 | Apolipoprotein A-II | 2.54e-04 | 5.24e-06 | NA |
2. P | Q1ELV0 | M-zodatoxin-Lt7a | 9.63e-05 | 2.29e-03 | NA |
2. P | P01257 | Calcitonin | 7.68e-04 | 3.38e-02 | NA |
2. P | Q9I9D3 | Pro-neuropeptide Y | 7.50e-03 | 2.80e-04 | NA |
2. P | Q06145 | Gastric inhibitory polypeptide | 1.94e-03 | 4.43e-02 | NA |
2. P | P0DMJ0 | Antimicrobial peptide HsAp4 | 2.10e-03 | 3.90e-02 | NA |
2. P | Q8TD33 | Secretoglobin family 1C member 1 | 6.34e-04 | 1.58e-03 | NA |
2. P | A0A5P9K6A8 | Dermaseptin-SP4 | 3.55e-04 | 1.74e-05 | NA |
2. P | Q17UZ0 | Distinctin-like peptide (Fragment) | 7.52e-04 | 3.21e-04 | NA |
2. P | Q2V305 | Defensin-like protein 219 | 8.30e-03 | 2.52e-03 | NA |
2. P | P04089 | Parathyroid hormone | 3.39e-05 | 4.38e-08 | NA |
2. P | A0A3G5BIB1 | U-Asilidin(12)-Dg3b | 3.08e-02 | 1.90e-02 | NA |
2. P | D2Y2G9 | U3-theraphotoxin-Hhn1p | 1.00e-01 | 7.44e-03 | NA |
2. P | Q6Y4S4 | Metastasis-suppressor KiSS-1 | 1.11e-01 | 4.20e-06 | NA |
2. P | P86471 | Defensin Lucifensin | 3.63e-02 | 1.75e-04 | NA |
2. P | A0A125S9D8 | Conotoxin Im28.1 | 1.57e-02 | 2.64e-02 | NA |
2. P | P08435 | Tachykinin-3 | 6.39e-02 | 6.05e-05 | NA |
2. P | Q9PUR0 | Glucagon-2 | 6.78e-04 | 5.83e-05 | NA |
2. P | P0DKU5 | Apolipoprotein C-II | 1.24e-03 | 2.17e-03 | NA |
2. P | P10082 | Peptide YY | 1.85e-02 | 6.65e-06 | NA |
2. P | Q09418 | Putative protein tag-209 | 2.73e-03 | 1.12e-03 | NA |
2. P | I0B6F2 | Chassatide C2 | 4.41e-04 | 1.37e-02 | NA |
2. P | P60042 | Somatostatin | 8.60e-03 | 3.42e-03 | NA |
2. P | Q9VLK4 | Diuretic hormone class 2 | 9.74e-03 | 3.76e-08 | NA |
2. P | R4JJN6 | Pantinin-3 | 1.57e-03 | 1.98e-02 | NA |
2. P | D2Y227 | U4-theraphotoxin-Hhn1h | 5.73e-05 | 3.17e-02 | NA |
2. P | Q1JS89 | Esculentin-2Vb | 2.77e-03 | 4.94e-02 | NA |
2. P | P0C666 | Conotoxin Ca5.1 | 3.38e-03 | 1.05e-02 | NA |
2. P | C0HKT2 | Pro-corazonin | 2.05e-02 | 6.03e-04 | NA |
2. P | P07660 | Calcitonin | 5.39e-03 | 1.07e-02 | NA |
2. P | P04640 | Osteocalcin | 2.10e-02 | 7.59e-10 | NA |
2. P | Q5G859 | Defensin-7 | 1.78e-03 | 1.26e-03 | NA |
2. P | P0DKW1 | Apolipoprotein C-IV | 6.56e-04 | 4.47e-05 | NA |
2. P | P05007 | Interferon alpha-A | 1.10e-02 | 4.83e-02 | NA |
2. P | P51923 | Progonadoliberin-3 | 9.02e-03 | 1.18e-02 | NA |
2. P | P08858 | Tachykinin-3 | 8.48e-02 | 1.00e-03 | NA |
2. P | Q93702 | FMRFamide-like neuropeptides 22 | 7.35e-02 | 6.90e-03 | NA |
2. P | F6JWU9 | Conotoxin Lt28.3 | 3.75e-02 | 2.34e-02 | NA |
2. P | P01352 | Gastrin | 1.16e-02 | 3.58e-04 | NA |
2. P | P18658 | Apolipoprotein C-II | 1.91e-03 | 4.77e-04 | NA |
2. P | P79897 | Guanylin | 5.24e-02 | 2.03e-03 | NA |
2. P | Q9GQW4 | Peptide BmKn1 | 6.15e-03 | 5.74e-03 | NA |
2. P | B1NWR6 | N.vectensis toxin 1 3 | 2.16e-03 | 2.70e-03 | NA |
2. P | O18496 | Styelin-E | 3.97e-03 | 2.36e-02 | NA |
2. P | O46167 | U1-agatoxin-Ta1b | 1.56e-01 | 1.57e-04 | NA |
2. P | Q8WSV4 | Andropin | 3.55e-04 | 1.09e-04 | NA |
2. P | Q6XE38 | Secretoglobin family 1D member 4 | 8.90e-04 | 1.09e-02 | NA |
2. P | P56595 | Apolipoprotein C-I | 6.53e-04 | 8.18e-05 | NA |
2. P | P41547 | Calcitonin | 8.68e-04 | 2.54e-03 | NA |
2. P | P13304 | Antiholin | NA | 4.77e-04 | NA |
2. P | Q9BLM1 | Probable neurotoxin pcD-996 | 3.45e-01 | 4.19e-02 | NA |
2. P | O57312 | Cholecystokinin | 2.05e-03 | 5.71e-04 | NA |
2. P | F8J4S0 | Oxyopinin-4a | 3.99e-04 | 3.85e-07 | NA |
2. P | Q95J46 | Urotensin-2 | 2.93e-02 | 5.74e-03 | NA |
2. P | P0DMN8 | Apolipoprotein C-IV | 2.15e-03 | 4.30e-05 | NA |
2. P | P45652 | Progonadoliberin-3 | 2.47e-02 | 6.65e-06 | NA |
2. P | Q8S8N0 | CLAVATA3/ESR (CLE)-related protein 4 | 8.29e-04 | 2.18e-02 | NA |
2. P | A0A172M418 | Secreted RxLR effector protein 2 | 1.13e-03 | 2.13e-02 | NA |
2. P | P0DTH2 | Apolipoprotein C-IV | 8.46e-04 | 1.75e-06 | NA |
2. P | Q2V4N0 | Putative defensin-like protein 110 | 1.77e-02 | 5.01e-03 | NA |
2. P | Q8SQD7 | Galanin-like peptide | 9.29e-02 | 5.32e-04 | NA |
2. P | D0NM15 | RxLR effector protein CRE10 | 1.13e-03 | 7.81e-05 | NA |
2. P | Q2V4D7 | Defensin-like protein 34 | 7.56e-02 | 2.77e-02 | NA |
2. P | P50722 | Hyphancin-3F | 1.19e-04 | 7.02e-03 | NA |
2. P | P0DN49 | Teretoxin Tsu6.15 | 7.51e-02 | 5.55e-03 | NA |
2. P | Q9N0V5 | Calcitonin | 3.42e-03 | 4.52e-04 | NA |
2. P | Q1JS88 | Palustrin-3b | 2.50e-03 | 2.60e-03 | NA |
2. P | P05113 | Interleukin-5 | 6.67e-03 | 2.25e-02 | NA |
2. P | Q3V3I5 | Uncharacterized protein C17orf67 homolog | 7.92e-05 | 5.02e-11 | NA |
2. P | Q92106 | Progonadoliberin-3 | 2.64e-02 | 8.11e-06 | NA |
2. P | Q9XSN5 | Apolipoprotein C-I | 6.04e-03 | 2.12e-03 | NA |
2. P | P0DM84 | Apolipoprotein C-I | 1.03e-03 | 1.55e-07 | NA |
2. P | G8F204 | Apolipoprotein C-I, acidic form | 4.90e-03 | 2.05e-05 | NA |
2. P | P0DPX0 | U-myrmeciitoxin(01)-Mg7b | 5.10e-04 | 1.16e-02 | NA |
2. P | Q800R3 | Phylloseptin-B1 | 2.23e-04 | 1.76e-02 | NA |
2. P | P0DTQ3 | Apolipoprotein C-I, acidic form | 4.80e-03 | 2.05e-05 | NA |
2. P | E2RAK7 | Apolipoprotein A-II | 3.77e-04 | 3.29e-05 | NA |
2. P | H9FNA4 | Apolipoprotein C-I, basic form | 2.59e-03 | 3.50e-07 | NA |
2. P | P10286 | Calcitonin gene-related peptide | 1.40e-03 | 6.78e-05 | NA |
2. P | P84019 | Cecropin-C | 2.54e-04 | 4.28e-08 | NA |
2. P | C5H0D5 | Esculentin-2-ALb | 3.73e-04 | 3.14e-03 | NA |
2. P | P0DQF5 | U-scoloptoxin(22)-Er1a | 3.72e-03 | 6.96e-03 | NA |
2. P | O93448 | UI | 4.91e-03 | 5.18e-04 | NA |
2. P | P69107 | Progonadoliberin-3 | 3.80e-02 | 3.34e-06 | NA |
2. P | P01355 | Cholecystokinin | 1.94e-02 | 7.08e-04 | NA |
2. P | P61278 | Somatostatin | 2.74e-03 | 1.61e-02 | NA |
2. P | P0DKU7 | Apolipoprotein C-I, acidic form | 3.16e-03 | 9.33e-07 | NA |
2. P | P0DKY1 | Apolipoprotein C-II | 1.27e-04 | 3.48e-04 | NA |
2. P | Q9XSE2 | Promotilin | 1.70e-03 | 3.99e-03 | NA |
2. P | A0A5P9K9Z4 | Dermaseptin-SP3 | 5.94e-04 | 3.65e-06 | NA |
2. P | P63292 | Somatoliberin | 3.47e-04 | 1.72e-04 | NA |
2. P | C5H0D4 | Esculentin-2-ALa | 2.75e-04 | 1.59e-03 | NA |
2. P | Q9GSA4 | Pro-corazonin | 3.07e-02 | 4.98e-02 | NA |
2. P | Q9Z2R5 | Apolipoprotein C-III | 2.58e-05 | 9.23e-04 | NA |
2. P | P81485 | Dermaseptin-B3 | 3.70e-04 | 1.86e-03 | NA |
2. P | P18830 | Adipokinetic prohormone type 1 | 8.46e-03 | 1.12e-06 | NA |
2. P | O13009 | Guanylate cyclase activator 2B | 1.31e-02 | 2.27e-04 | NA |
2. P | P0DQB7 | U-scoloptoxin(15)-Sa1a | 1.65e-01 | 7.42e-06 | NA |
2. P | Q8UW80 | Progonadoliberin-1 | 1.69e-02 | 7.52e-05 | NA |
2. P | P0DM96 | Apolipoprotein A-II | 2.03e-04 | 2.70e-06 | NA |
2. P | P81603 | Defensin-C | 5.13e-02 | 4.36e-02 | NA |
2. P | P84021 | Cecropin-C | 5.76e-04 | 4.28e-08 | NA |
2. P | Q2V325 | Putative defensin-like protein 40 | 2.95e-01 | 3.84e-02 | NA |
2. P | Q09953 | Uncharacterized protein F59B10.5 | 1.65e-01 | 9.78e-05 | NA |
2. P | P51918 | Progonadoliberin-1 | 1.66e-02 | 1.06e-07 | NA |
2. P | Q90Y63 | Progonadoliberin-1 | 2.41e-02 | 1.59e-08 | NA |
2. P | Q9H1Z8 | Augurin | 1.95e-02 | 4.77e-03 | NA |
2. P | A0A193H397 | Cruzioseptin-12 | 2.83e-04 | 3.21e-06 | NA |
2. P | Q9DG36 | Progonadoliberin-2 | 1.74e-03 | 1.45e-09 | NA |
2. P | P26886 | Mating pheromone Er-2/Er-9 | 8.99e-04 | 1.61e-02 | NA |
2. P | P0DMI8 | Antimicrobial peptide HsAp2 | 6.68e-04 | 3.41e-02 | NA |
2. P | P01299 | Pancreatic prohormone | 2.37e-02 | 6.72e-05 | NA |
2. P | Q9BPJ5 | Conotoxin TxMMSK-04 | 7.10e-02 | 4.39e-02 | NA |
2. P | P0CV69 | Secreted RxLR effector protein 158 | 5.85e-02 | 1.87e-04 | NA |
2. P | Q17UY8 | Dermaseptin-H3 | 5.40e-04 | 4.73e-03 | NA |
2. P | Q9BHA6 | Conotoxin Ar5.1 a | 1.58e-04 | 1.42e-03 | NA |
2. P | Q3V2D2 | Uncharacterized protein C5orf46 homolog | 2.02e-03 | 8.67e-08 | NA |
2. P | B6HY15 | Adenoregulin-related peptide | 4.83e-05 | 3.17e-05 | NA |
2. P | Q8QGA2 | Tuberoinfundibular peptide of 39 residues | 5.14e-03 | 3.74e-04 | NA |
2. P | P0DP87 | Apolipoprotein A-II | 1.04e-04 | 7.96e-08 | NA |
2. P | P17640 | Pro-MCH 1 | 2.75e-02 | 1.71e-03 | NA |
2. P | C0HJZ9 | Ocellatin-PT4 | 1.46e-03 | 7.94e-04 | NA |
2. P | E7EKH6 | Brevinin-2SN3 | 1.24e-03 | 3.32e-05 | NA |
2. P | O93224 | Dermaseptin-A4 | 1.07e-04 | 9.62e-03 | NA |
2. P | P0CV06 | Secreted RxLR effector protein 37 | 4.14e-03 | 1.19e-02 | NA |
2. P | Q6IGX9 | Neuropeptide SIFamide | 3.39e-03 | 8.18e-05 | NA |
2. P | A0A348G5V9 | U-poneritoxin(01)-Om3a | 1.17e-04 | 2.33e-05 | NA |
2. P | Q9QXQ6 | Galanin-like peptide | 7.92e-02 | 8.74e-05 | NA |
2. P | P0DP53 | Apolipoprotein C-IV | 2.45e-03 | 1.04e-04 | NA |
2. P | C0HK00 | Ocellatin-PT5 | 9.70e-03 | 4.57e-03 | NA |
2. P | Q5DW47 | Pro-corazonin | 7.80e-03 | 1.41e-04 | NA |
2. P | B3IWF9 | Calcitonin receptor-stimulating peptide 1 | 1.37e-03 | 1.32e-03 | NA |
2. P | P37085 | Pigment-dispersing hormone A peptides | 1.47e-02 | 2.24e-05 | NA |
2. P | P0DMT9 | Apolipoprotein C-II | 5.22e-04 | 8.77e-08 | NA |
2. P | P24511 | Chorion protein S16 | 1.29e-02 | 1.33e-04 | NA |
2. P | P01286 | Somatoliberin | 6.86e-05 | 2.29e-03 | NA |
2. P | P0CU99 | Secreted RxLR effector protein 20 | 3.75e-04 | 2.25e-06 | NA |
2. P | P01171 | Somatostatin-1 | 5.93e-04 | 2.54e-02 | NA |
2. P | P23362 | Cholecystokinin | 1.30e-03 | 2.99e-05 | NA |
2. P | P0DP52 | Apolipoprotein C-II | 6.45e-04 | 6.99e-08 | NA |
2. P | P0DUP5 | Apolipoprotein C-IV | 1.11e-02 | 3.02e-08 | NA |
2. P | C0HK03 | Ocellatin-PT8 | 8.00e-04 | 4.88e-08 | NA |
2. P | Q9BH81 | Conotoxin ArMLCL-012 | 1.05e-02 | 3.25e-02 | NA |
2. P | Q8AXR2 | C-type natriuretic peptide 2 | 2.25e-02 | 2.70e-04 | NA |
2. P | Q571V3 | Frenatin 4.1 | 3.41e-04 | 1.24e-05 | NA |
2. P | A9XFZ7 | Defensin coprisin | 4.08e-02 | 2.21e-03 | NA |
2. P | P83403 | Cecropin | 1.38e-03 | 1.33e-07 | NA |
2. P | P0DP85 | Apolipoprotein A-II | 3.22e-04 | 7.96e-08 | NA |
2. P | O24602 | CLAVATA3/ESR (CLE)-related protein ESR1 | 1.02e-02 | 3.18e-04 | NA |
2. P | P40844 | Esculentin-1B | 1.84e-03 | 1.13e-03 | NA |
2. P | Q27IM2 | Parathyroid hormone | 3.48e-03 | 4.72e-08 | NA |
2. P | P81644 | Apolipoprotein A-II | 2.41e-04 | 1.18e-03 | NA |
2. P | E7EKI0 | Esculentin-2SN1 | 2.00e-04 | 5.56e-05 | NA |
2. P | P12872 | Promotilin | 8.35e-02 | 1.81e-03 | NA |
2. P | P47851 | Gastrin-releasing peptide | 4.18e-04 | 2.85e-05 | NA |
2. P | P0DPH1 | Apolipoprotein C-I | 2.26e-04 | 2.42e-06 | NA |
2. P | B1NWS8 | N.vectensis toxin 1 6 | 1.39e-02 | 2.52e-02 | NA |
2. P | Q765I2 | Urotensin-2B | 7.38e-03 | 2.22e-05 | NA |
2. P | Q2T9U8 | Neuromedin-B | 1.69e-02 | 5.30e-05 | NA |
2. P | P30973 | Progonadoliberin-3 | 5.37e-02 | 2.67e-06 | NA |
2. P | F1T152 | Palustrin-2ISa | 6.50e-05 | 1.81e-02 | NA |
2. P | O76146 | Cecropin-D | 8.41e-04 | 4.30e-05 | NA |
2. P | O42413 | Matrix Gla protein | 2.37e-02 | 6.03e-04 | NA |
2. P | P49670 | Somatostatin | 1.90e-04 | 1.42e-02 | NA |
2. P | Q9PT99 | Peptide YY-like | 1.52e-02 | 5.16e-08 | NA |
2. P | P0DN44 | Tan_10cys | 1.56e-02 | 2.90e-06 | NA |
2. P | E7EKH7 | Brevinin-2SN4 | 9.62e-04 | 1.20e-05 | NA |
2. P | P61279 | Somatostatin | 2.43e-03 | 1.61e-02 | NA |
2. P | P0DTR6 | Apolipoprotein C-I, acidic form | 5.69e-03 | 1.86e-05 | NA |
2. P | Q9PTQ4 | UI | 6.19e-04 | 8.11e-06 | NA |
2. P | Q6EAL8 | Interleukin-31 | 3.46e-03 | 1.28e-02 | NA |
2. P | A0AEI5 | Brevinin-2GHb | 3.89e-04 | 5.51e-04 | NA |
2. P | P48144 | Glucagon family neuropeptides | 8.17e-03 | 1.47e-02 | NA |
2. P | A0A193H361 | Cruzioseptin-11 | 1.62e-03 | 8.83e-04 | NA |
2. P | Q28HK1 | Unique cartilage matrix-associated protein | 7.26e-04 | 2.93e-04 | NA |
2. P | D2Y2G7 | U3-theraphotoxin-Hhn1n | 1.13e-02 | 1.82e-02 | NA |
2. P | P01508 | Cecropin-B | 2.80e-03 | 4.82e-04 | NA |
2. P | Q76CL2 | Peptide YY | 1.60e-02 | 5.51e-06 | NA |
2. P | P0DKW2 | Apolipoprotein C-IV | 1.78e-03 | 3.06e-07 | NA |
2. P | C3RT24 | Rugosin-LK2 | 2.38e-04 | 1.80e-03 | NA |
2. P | Q99JA0 | Calcitonin gene-related peptide 1 | 9.39e-04 | 4.22e-02 | NA |
2. P | P56943 | Pro-MCH 1 | 1.79e-01 | 5.35e-05 | NA |
2. P | P34928 | Apolipoprotein C-I | 1.52e-03 | 2.72e-05 | NA |
2. P | P0DTG8 | Apolipoprotein C-I | 2.21e-04 | 7.64e-06 | NA |
2. P | Q9BPD2 | Conotoxin ArMLCL-022 | 9.15e-04 | 6.84e-03 | NA |
2. P | O46168 | U1-agatoxin-Ta1c | 2.49e-01 | 5.01e-03 | NA |
2. P | C0HKQ7 | Cecropin-A1 | 2.99e-04 | 1.17e-06 | NA |
2. P | P0DPH2 | Apolipoprotein C-I | 1.47e-03 | 6.29e-05 | NA |
2. P | P69019 | Aurein-2.5 | 4.53e-03 | 2.94e-03 | NA |
2. P | A0A2Y9GDB5 | Apolipoprotein C-IV | 2.08e-03 | 4.78e-09 | NA |
2. P | Q9M2Y0 | Phytosulfokines 3 | 3.05e-02 | 8.60e-04 | NA |
2. P | P58924 | Sigma-conotoxin GVIIIA | 6.85e-02 | 3.20e-02 | NA |
2. P | E2ASG4 | SIFamide-related peptide | 9.64e-04 | 1.05e-09 | NA |
2. P | E4Z7G0 | Kassorin-M | 1.69e-03 | 3.89e-03 | NA |
2. P | W4VRX8 | Toxin ICK-12 | 4.74e-02 | 8.50e-03 | NA |
2. P | P0DTH1 | Apolipoprotein C-IV | 1.02e-03 | 4.75e-07 | NA |
2. P | Q1HA20 | Neuromedin-S | 1.13e-02 | 2.98e-02 | NA |
2. P | P61103 | Mu-theraphotoxin-Hs1a | 4.42e-02 | 7.19e-03 | NA |
2. P | P13204 | Natriuretic peptides B | 6.85e-03 | 1.59e-03 | NA |
2. P | P41319 | C-type natriuretic peptide | 9.41e-04 | 7.95e-03 | NA |
2. P | O62688 | Pro-MCH (Fragment) | 5.39e-03 | 3.28e-02 | NA |
2. P | A0A348G5W2 | U-poneritoxin(01)-Om6a | 1.84e-04 | 5.19e-03 | NA |
2. P | P50708 | Alpha-defensin 10 | 1.93e-01 | 4.64e-02 | NA |
2. P | F1T151 | Esculentin-2ISa | 1.68e-03 | 2.52e-05 | NA |
2. P | Q3SYR5 | Apolipoprotein C-IV | 1.52e-03 | 1.33e-04 | NA |
2. P | Q8R1I2 | Gastrin-releasing peptide | 5.52e-03 | 2.27e-03 | NA |
2. P | P01302 | Pancreatic prohormone | 1.96e-02 | 1.87e-02 | NA |
2. P | P81941 | Pleurocidin | 1.97e-03 | 1.88e-02 | NA |
2. P | P0DPG0 | Apolipoprotein C-I, acidic form | 4.43e-03 | 2.54e-06 | NA |
2. P | Q8MMH4 | Small venom protein 2 | 6.89e-04 | 1.44e-09 | NA |
2. P | P0DKV5 | Apolipoprotein C-I | 2.92e-03 | 9.97e-06 | NA |
2. P | Q9BH79 | Conotoxin Ar5.3 | 4.00e-04 | 2.49e-03 | NA |
2. P | A0A182BSS2 | Secreted RxLR effector protein 49 | 1.60e-02 | 7.35e-07 | NA |
2. P | D0P1B2 | RxLR effector protein SFI8 | 6.25e-02 | 2.00e-04 | NA |
2. P | P35807 | Adipokinetic prohormone type 2 | 2.34e-04 | 7.42e-06 | NA |
2. P | B6HY16 | Dermaseptin-related peptide | 4.44e-04 | 1.45e-05 | NA |
2. P | Q91826 | PYLa/PGLa B | 9.85e-05 | 1.36e-03 | NA |
2. P | E1AXF6 | Esculentin-2MT1 | 3.35e-04 | 1.12e-03 | NA |
2. P | B5LUQ4 | Preprofallaxidin-1 | 8.55e-03 | 1.54e-02 | NA |
2. P | E1AXF5 | Brevinin-2MT1 | 2.08e-04 | 3.99e-05 | NA |
2. P | Q800R4 | Plasticin-B1 | 2.65e-03 | 3.30e-04 | NA |
2. P | Q6DJ00 | Osteocalcin | 2.93e-03 | 1.06e-05 | NA |
2. P | P29007 | Gastrin-releasing peptide | 5.36e-03 | 1.13e-05 | NA |
2. P | P0DKV4 | Apolipoprotein C-I | 1.80e-03 | 3.23e-05 | NA |
2. P | P82390 | Aurein-2.3 | 7.12e-03 | 1.51e-03 | NA |
2. P | P87384 | Somatostatin-1 | 1.50e-03 | 2.63e-04 | NA |
2. P | Q3V2T4 | Keratinocyte differentiation-associated protein | 6.32e-02 | 6.49e-09 | NA |
2. P | P28673 | Pro-neuropeptide Y | 1.11e-02 | 2.72e-04 | NA |
2. P | Q9YGH5 | Somatostatin-1A | 2.17e-04 | 1.49e-04 | NA |
2. P | Q09401 | Uncharacterized protein K02A2.5 | 2.25e-03 | 1.24e-06 | NA |
2. P | L0GCV8 | Antimicrobial peptide UyCT1 | 1.48e-05 | 4.22e-02 | NA |
2. P | Q75V95 | Calcitonin receptor-stimulating peptide 1 | 1.12e-03 | 5.06e-03 | NA |
2. P | P08493 | Matrix Gla protein | 9.28e-03 | 7.31e-05 | NA |
2. P | Q86QI5 | Defensin | 4.20e-03 | 3.23e-02 | NA |
2. P | P0DKU6 | Apolipoprotein C-IV | 2.03e-03 | 4.47e-08 | NA |
2. P | P0CV70 | Secreted RxLR effector protein 159 | 2.71e-02 | 1.10e-03 | NA |
2. P | A8MR88 | EMBRYO SURROUNDING FACTOR 1-like protein 8 | 1.84e-01 | 3.75e-02 | NA |
2. P | Q18184 | FMRFamide-like neuropeptides 27 | 3.94e-02 | 4.05e-08 | NA |
2. P | P09240 | Cholecystokinin | 5.48e-03 | 8.99e-04 | NA |
2. P | Q9JI02 | Secretoglobin family 2B member 20 | 1.03e-02 | 1.42e-02 | NA |
2. P | D2Y2N0 | U3-theraphotoxin-Hhn1a 17 | 3.03e-02 | 4.06e-02 | NA |
2. P | P10683 | Galanin peptides | 3.72e-02 | 1.20e-08 | NA |
2. P | P0DPY5 | U-scoloptoxin(10)-Sm2a | 5.50e-04 | 2.70e-03 | NA |
2. P | D0NIY2 | RxLR effector protein PITG_11507 | 1.94e-01 | 2.72e-03 | NA |
2. P | P0DMF4 | Peptide Ctry2606 | 4.77e-03 | 4.57e-03 | NA |
2. P | P0DTG2 | Apolipoprotein C-I | 1.69e-03 | 8.36e-03 | NA |
2. P | P0DMR2 | Secretoglobin family 1C member 2 | 1.10e-03 | 1.54e-03 | NA |
2. P | P01263 | Calcitonin-1 | 5.96e-04 | 1.74e-02 | NA |
2. P | Q8WSV0 | Andropin | 7.95e-03 | 1.35e-02 | NA |
2. P | P0DTH0 | Apolipoprotein C-IV | 1.38e-03 | 7.11e-05 | NA |
2. P | P51744 | Interleukin-4 | 1.99e-03 | 7.63e-03 | NA |
2. P | Q9XS58 | Interleukin-4 | 1.38e-03 | 1.08e-02 | NA |
2. P | Q00676 | Bradykinin-like neuropeptide | 4.22e-02 | 1.83e-03 | NA |
2. P | P55056 | Apolipoprotein C-IV | 7.03e-04 | 1.43e-04 | NA |
2. P | Q9XSV9 | Interleukin-13 | 3.03e-02 | 2.16e-02 | NA |
2. P | D0NTY1 | RxLR effector protein Avr-vnt11 | 1.61e-03 | 2.91e-03 | NA |
2. P | P21591 | Bombesin | 1.17e-04 | 6.67e-03 | NA |
2. P | P0DPT5 | U-scoloptoxin(15)-Sm2a | 1.99e-01 | 1.71e-03 | NA |
2. P | E1AWD6 | Brevinin-2CG1 | 5.96e-04 | 8.26e-05 | NA |
2. P | A0A2Y9GHM8 | Apolipoprotein C-II | 1.36e-03 | 1.86e-07 | NA |
2. P | P0DME4 | Peptide Ctri10033 | 4.11e-04 | 4.65e-04 | NA |
2. P | Q1EN13 | Dermaseptin-S11 | 2.41e-04 | 1.13e-02 | NA |
2. P | Q30KJ4 | Beta-defensin 135 | 7.81e-02 | 1.30e-02 | NA |
2. P | B8XH40 | Potassium channel toxin BuTXK-beta | 2.95e-02 | 1.18e-02 | NA |
2. P | C0HKT3 | Diuretic hormone class 2 | 2.44e-04 | 1.32e-03 | NA |
2. P | Q1A3Q2 | Conotoxin Lt5.11 | 1.04e-03 | 6.08e-03 | NA |
2. P | P55319 | Adipokinetic prohormone type 1 | 4.69e-02 | 2.47e-06 | NA |
2. P | A0A348G5V8 | U-poneritoxin(01)-Om2a | 5.40e-04 | 1.15e-04 | NA |
2. P | D6C4L9 | Conotoxin Cl9.2 | 6.43e-02 | 1.87e-02 | NA |
2. P | Q800R9 | Caerin 1.11 | 1.03e-03 | 2.48e-02 | NA |
2. P | P23442 | Islet amyloid polypeptide | 4.84e-02 | 3.80e-05 | NA |
2. P | P37997 | Interleukin-2 | 2.01e-02 | 2.67e-03 | NA |
2. P | A0A348G6I9 | U-poneritoxin(01)-Om4b | 9.79e-04 | 2.98e-02 | NA |
2. P | B5A9T0 | Dybowskin-2CDYb | 3.60e-03 | 4.94e-02 | NA |
2. P | M4C319 | RxLR effector protein 62 | 4.31e-03 | 2.00e-04 | NA |
2. P | E7EKH1 | Brevinin-1SN1 | 1.01e-03 | 1.03e-02 | NA |
2. P | Q2V2Q0 | Putative uncharacterized protein YDL007C-A | 1.27e-05 | 3.49e-02 | NA |
2. P | P41520 | Cholecystokinin | 4.58e-02 | 1.64e-06 | NA |
2. P | G4ZSG0 | RxLR effector protein Avh52 | 1.81e-03 | 1.79e-04 | NA |
2. P | P01148 | Progonadoliberin-1 | 3.69e-03 | 2.42e-07 | NA |
2. P | P35318 | Pro-adrenomedullin | 2.90e-02 | 1.51e-02 | NA |
2. P | P49794 | Pro-MCH | 9.41e-02 | 4.89e-03 | NA |
2. P | P85411 | Keratinocyte differentiation-associated protein | 7.58e-02 | 2.54e-05 | NA |
2. P | P0DKV2 | Apolipoprotein C-I | 2.36e-03 | 5.72e-05 | NA |
2. P | C6ZH27 | Neurotoxin beta-KTx 17 | 1.46e-02 | 1.28e-02 | NA |
2. P | Q0GY41 | Potassium channel toxin Hge-beta-KTx | 1.92e-03 | 1.56e-02 | NA |
2. P | C7G3K3 | Beta-KTx-like peptide LaIT2 | 1.00e-01 | 4.46e-02 | NA |
2. P | Q99LS0 | Augurin | 1.29e-02 | 7.14e-04 | NA |
2. P | O97383 | Crustacean hyperglycemic hormones 1 | 4.26e-02 | 4.72e-02 | NA |
2. P | D2Y2G6 | U3-theraphotoxin-Hhn1a 11 | 1.71e-02 | 4.94e-02 | NA |
2. P | P50724 | Cecropin-A | 2.96e-03 | 5.88e-05 | NA |
2. P | A0A5P9K470 | Dermaseptin-SP2 | 3.58e-04 | 6.00e-05 | NA |
2. P | G5EHI7 | Biotrophy-associated secreted protein 1 | 5.49e-02 | 1.16e-02 | NA |
2. P | I3LGZ3 | Protein GPR15L | 9.91e-03 | 4.52e-04 | NA |
2. P | P0DOC4 | Apolipoprotein C-IV | 1.86e-03 | 4.12e-06 | NA |
2. P | O93464 | Cholecystokinin | 2.21e-02 | 9.86e-03 | NA |
2. P | P07490 | Progonadoliberin-1 | 2.34e-03 | 1.01e-07 | NA |
2. P | P08375 | Sarcotoxin-1A | 1.81e-03 | 5.18e-04 | NA |
2. P | P01170 | Somatostatin-2 | 1.22e-02 | 2.29e-02 | NA |
2. P | Q18060 | Probable insulin-like peptide gamma-type 1 | 1.53e-02 | 3.09e-03 | NA |
2. P | P0DKY3 | Apolipoprotein C-IV | 1.19e-03 | 6.94e-09 | NA |
2. P | A0A6G9KHD6 | U10-myrmicitoxin-Mri1c | 1.42e-02 | 4.87e-02 | NA |
2. P | Q0VZ40 | Phylloseptin-H7 | 4.79e-04 | 1.57e-04 | NA |
2. P | Q99134 | PYLa/PGLa A | 4.40e-04 | 1.74e-04 | NA |
2. P | P81685 | Cecropin-A1 | 4.35e-04 | 2.53e-07 | NA |
2. P | D5KXH6 | Turripeptide IX-03 | 3.01e-02 | 1.31e-03 | NA |
2. P | P18104 | C-type natriuretic peptide | 4.39e-03 | 4.36e-02 | NA |
2. P | A0A286SC82 | RxLR effector protein BLR31 | 2.93e-02 | 9.22e-06 | NA |
2. P | Q62714 | Neutrophil antibiotic peptide NP-4 | 2.33e-01 | 1.12e-02 | NA |
2. P | D0MRS3 | RxLR effector protein PexRD21 | 1.65e-02 | 8.99e-04 | NA |
2. P | G3MU46 | Neuropeptide-like protein 38 | 2.79e-02 | 1.25e-03 | NA |
2. P | P0DN51 | Teretoxin Tan6.1 | 7.60e-02 | 5.44e-07 | NA |
2. P | P19939 | Apolipoprotein C-I | 1.80e-03 | 1.10e-03 | NA |
2. P | A4H207 | Beta-defensin 105A | 1.62e-03 | 2.25e-02 | NA |
2. P | E1AXF9 | Amolopin-p-MT1 | 2.31e-04 | 1.93e-02 | NA |
2. P | P49921 | Progonadoliberin-1 | 3.32e-03 | 1.31e-09 | NA |
2. P | Q8FBY0 | Uncharacterized protein YicS | 6.71e-02 | 1.25e-02 | NA |
2. P | B3FIA5 | Conotoxin Vi15a | 3.22e-01 | 3.03e-02 | NA |
2. P | Q8WRC7 | Cardioactive peptide | 6.32e-04 | 8.77e-07 | NA |
2. P | Q0N4U4 | Alpha/kappa-conotoxin-like fe14.1 | 5.30e-02 | 2.13e-02 | NA |
2. P | Q9GLK4 | Natriuretic peptides B | 3.79e-03 | 1.28e-02 | NA |
2. P | E2AJ76 | Short neuropeptide F | 1.26e-02 | 1.10e-05 | NA |
2. P | Q5WQZ7 | Opiscorpine-3 | 4.07e-02 | 3.07e-02 | NA |
2. P | C3RT17 | Gaegurin-LK1 | 2.12e-03 | 4.03e-02 | NA |
2. P | P02656 | Apolipoprotein C-III | 2.54e-04 | 3.45e-04 | NA |
2. P | Q9MZ28 | Sperm-associated antigen 11 | 3.34e-01 | 1.50e-02 | NA |
2. P | P0DKP7 | Alpha-conotoxin CnIJ | 1.38e-02 | 6.29e-03 | NA |
2. P | P0DUP3 | Apolipoprotein C-II | 1.05e-03 | 4.87e-05 | NA |
2. P | C3TS10 | Delta-actitoxin-Avd2b 3 | 4.29e-03 | 3.81e-02 | NA |
2. P | Q9EQX0 | Appetite-regulating hormone | 1.39e-02 | 5.16e-07 | NA |
2. P | P0DKW4 | Apolipoprotein C-IV | 1.09e-03 | 4.32e-07 | NA |
2. P | B4G535 | Protein Turandot Z | 9.16e-04 | 2.38e-02 | NA |
2. P | Q765I0 | Urotensin-2B | 1.18e-03 | 2.67e-09 | NA |
2. P | Q800Y1 | Osteocalcin | 4.67e-02 | 1.71e-02 | NA |
2. P | B6HY14 | Caerin-regulated peptide | 6.47e-04 | 1.02e-04 | NA |
2. P | P02822 | Osteocalcin | 3.34e-02 | 2.21e-04 | NA |
2. P | A0A0A7DNP6 | Prepro-gonadotropin-releasing hormone-like protein | 1.27e-02 | 2.47e-09 | NA |
2. P | C3Z6E6 | QRFP-like peptide | 1.16e-01 | 6.59e-05 | NA |
2. P | P07712 | Abdominal ganglion neuropeptides L5-67 | 3.99e-02 | 2.44e-06 | NA |
2. P | W4VSI7 | Toxin ICK-13 | 6.26e-03 | 1.59e-02 | NA |
2. P | P01307 | Promotilin | 7.14e-03 | 2.93e-04 | NA |
2. P | P84348 | Osteocalcin | 4.95e-02 | 1.93e-02 | NA |
2. P | Q9V3J3 | Accessory gland-specific peptide 57Dc | 2.62e-02 | 2.19e-03 | NA |
2. P | A9XE60 | Potassium channel toxin MeuTXK-beta-1 | 4.47e-02 | 2.32e-02 | NA |
2. P | B1P1A7 | U3-theraphotoxin-Cg1b | 8.04e-03 | 3.30e-02 | NA |
2. P | Q95JB4 | Liver-expressed antimicrobial peptide 2 | 1.60e-02 | 2.77e-04 | NA |
2. P | P86968 | Uncharacterized shell protein 4 | 2.43e-03 | 4.43e-05 | NA |
2. P | D6C4I6 | Conotoxin Cl14.12 | 2.11e-03 | 2.98e-04 | NA |
2. P | P26349 | Exendin-4 | 6.14e-05 | 1.76e-06 | NA |
2. P | F1T149 | Esculentin-1SIa | 1.23e-02 | 2.29e-03 | NA |
2. P | P07198 | Xenopsin peptides | 7.72e-05 | 4.22e-05 | NA |
2. P | Q28809 | Interleukin-3 | 1.33e-02 | 2.25e-06 | NA |
2. P | D2Y243 | U3-theraphotoxin-Hhn1a 4 | 1.13e-01 | 2.27e-02 | NA |
2. P | P70107 | Guanylate cyclase activator 2B | 2.68e-02 | 1.05e-07 | NA |
2. P | P08700 | Interleukin-3 | 6.30e-03 | 2.18e-06 | NA |
2. P | D2Y2M6 | U3-theraphotoxin-Hhn1a 15 | 1.72e-02 | 1.09e-02 | NA |
2. P | Q8K4N3 | Beta-defensin 12 | 7.06e-02 | 1.75e-02 | NA |
2. P | P17716 | Islet amyloid polypeptide | 1.47e-02 | 2.59e-05 | NA |
2. P | P81688 | Cecropin-A1 | 2.73e-04 | 1.12e-06 | NA |
2. P | P0DUP6 | Apolipoprotein C-IV | 6.17e-03 | 5.73e-07 | NA |
2. P | P0CV51 | Secreted RxLR effector protein 123 | 5.13e-03 | 3.27e-04 | NA |
2. P | P01146 | UI | 1.95e-03 | 2.11e-05 | NA |
2. P | P0DKU8 | Apolipoprotein C-I, basic form | 2.66e-03 | 6.47e-05 | NA |
2. P | A0MLS4 | Appetite-regulating hormone | 1.79e-02 | 1.20e-04 | NA |
2. P | P0DPG1 | Apolipoprotein C-I, basic form | 2.36e-03 | 3.50e-07 | NA |
2. P | G1AS80 | Conotoxin Vc6.14 | 3.89e-02 | 3.66e-02 | NA |
2. P | P55246 | Progonadoliberin-3 (Fragment) | 6.37e-02 | 3.63e-03 | NA |
2. P | Q1A3R3 | Conotoxin Lt5.1 | 1.62e-02 | 2.52e-02 | NA |
2. P | A7SCE5 | N.vectensis toxin 1 7 | 5.08e-03 | 7.33e-04 | NA |
2. P | Q2U3M0 | Fungal defensin oryzeasin | 8.33e-02 | 1.51e-02 | NA |
2. P | P0CV20 | Secreted RxLR effector protein 69 | 2.70e-02 | 7.88e-03 | NA |
2. P | Q8AUU1 | Ghrelin | 3.10e-03 | 1.80e-03 | NA |
2. P | Q95336 | Progonadoliberin-2 | 7.80e-02 | 1.52e-05 | NA |
2. P | Q3LHH8 | Exocrine gland-secreted peptide 1 | 9.81e-03 | 5.37e-04 | NA |
2. P | Q9PU29 | Cholecystokinin | 7.63e-03 | 1.92e-05 | NA |
2. P | Q9DGC8 | Progonadoliberin-1 | 1.34e-03 | 1.37e-11 | NA |
2. P | P01172 | Somatostatin-2 | 4.97e-02 | 2.05e-04 | NA |
2. P | A0A023W163 | U-scoloptoxin-Er5e | 1.33e-05 | 1.25e-02 | NA |
2. P | P40842 | Brevinin-2Ef | 5.33e-04 | 3.57e-03 | NA |
2. P | Q863C3 | Gastrin-releasing peptide | 5.80e-03 | 5.38e-07 | NA |
2. P | P69156 | Pro-MCH 2 | 2.47e-02 | 1.64e-05 | NA |
2. P | Q963A8 | Cecropin-C type 2 | 5.71e-04 | 2.15e-03 | NA |
2. P | Q9UBC7 | Galanin-like peptide | 7.37e-02 | 2.96e-05 | NA |
2. P | P24302 | Dermaseptin-S1 | 8.74e-04 | 2.80e-04 | NA |
2. P | D2Y250 | U3-theraphotoxin-Hhn1a 7 | 1.34e-02 | 2.23e-02 | NA |
2. P | Q6EBC2 | Interleukin-31 | 1.98e-03 | 1.51e-04 | NA |
2. P | Q08648 | Sperm-associated antigen 11B | 1.32e-01 | 1.13e-03 | NA |
2. P | P69109 | Progonadoliberin-3 | 3.28e-02 | 3.34e-06 | NA |
2. P | P0DKV3 | Apolipoprotein C-I | 2.13e-03 | 2.82e-05 | NA |
2. P | Q8WPA1 | Andropin | 5.67e-04 | 5.08e-06 | NA |
2. P | P07492 | Gastrin-releasing peptide | 3.50e-03 | 1.29e-03 | NA |
2. P | H2A0N7 | Uncharacterized shell protein 8 | 9.69e-03 | 4.51e-07 | NA |
2. P | P0DJD2 | Apolipoprotein A-II | 1.61e-04 | 6.56e-07 | NA |
2. P | P69769 | Kappa-conotoxin RIIIK | 3.33e-02 | 1.65e-02 | NA |
2. P | Q6UWT4 | Uncharacterized protein C5orf46 | 1.56e-03 | 3.12e-04 | NA |
2. P | P45656 | Progonadoliberin-1 | 4.79e-03 | 6.25e-11 | NA |
2. P | P0DP55 | Pro-neuropeptide Y | 1.19e-02 | 2.12e-06 | NA |
2. P | P70074 | Progonadoliberin-1 | 2.26e-02 | 2.52e-05 | NA |
2. P | F7UI86 | Phylloseptin-S3 | 1.49e-03 | 2.19e-04 | NA |
2. P | F4JRC5 | PAMP-induced secreted peptide 2 | 4.58e-02 | 7.02e-03 | NA |
2. P | D2Y2P1 | Hainantoxin-XVIII-7 | 9.01e-01 | 3.30e-02 | NA |
2. P | Q95M25 | Liver-expressed antimicrobial peptide 2 | 1.06e-02 | 8.45e-04 | NA |
2. P | P79695 | Pro-glucagon | 9.68e-03 | 6.23e-07 | NA |
2. P | Q94557 | Cecropin-1/3 | 2.51e-04 | 5.93e-09 | NA |
2. P | E1B243 | Esculentin-2MT3 | 2.60e-04 | 1.80e-03 | NA |
2. P | Q0P5P2 | Uncharacterized protein C17orf67 | 4.65e-04 | 9.33e-07 | NA |
2. P | Q3L180 | Alpha-defensin 26 | 2.47e-01 | 3.76e-03 | NA |
2. P | Q70XC3 | Allatotropin | 1.27e-01 | 5.01e-03 | NA |
2. P | Q9BPE0 | Conotoxin Vn5.6 | 4.68e-04 | 1.33e-04 | NA |
2. P | D5KXG8 | Turripeptide IX-01 | 1.01e-02 | 1.36e-03 | NA |
2. P | P0DTQ6 | Apolipoprotein C-II | 1.96e-03 | 2.76e-06 | NA |
2. P | Q6BEG6 | Appetite-regulating hormone | 1.30e-02 | 1.14e-05 | NA |
2. P | E7EKE1 | Brevinin-2HS2B | 1.27e-03 | 1.61e-06 | NA |
2. P | B9TQX2 | Unique cartilage matrix-associated protein | 3.59e-04 | 1.34e-05 | NA |
2. P | P0DPH3 | Apolipoprotein C-I | 3.27e-04 | 8.34e-05 | NA |
2. P | Q60549 | Somatoliberin | 4.75e-04 | 6.67e-03 | NA |
2. P | E7EZ53 | Galanin peptides | 5.41e-03 | 2.44e-09 | NA |
2. P | O75556 | Mammaglobin-B | 1.92e-03 | 1.30e-02 | NA |
2. P | A0A125S9G0 | Conotoxin Im026 | 1.67e-02 | 2.04e-02 | NA |
2. P | Q9W6M9 | Galanin peptides | 1.40e-02 | 1.45e-12 | NA |
2. P | P81564 | Skin calcitonin gene-related peptide | 7.59e-03 | 3.33e-04 | NA |
2. P | Q9MYV1 | Calcitonin gene-related peptide 1 | 1.88e-03 | 4.34e-03 | NA |
2. P | P80713 | Clavanin-D | 1.99e-03 | 1.28e-04 | NA |
2. P | P67788 | Adipokinetic prohormone | 2.19e-03 | 3.21e-06 | NA |
2. P | T1W425 | Apolipoprotein C-II | 1.18e-03 | 2.20e-09 | NA |
2. P | Q9BPD7 | Conotoxin TsMLCL-02 | 4.69e-04 | 6.73e-03 | NA |
2. P | P30438 | Major allergen I polypeptide chain 1 | 4.82e-03 | 2.30e-07 | NA |
2. P | D2Y247 | U3-theraphotoxin-Hhn1m | 3.58e-02 | 4.81e-03 | NA |
2. P | O09051 | Guanylate cyclase activator 2B | 4.00e-02 | 2.37e-06 | NA |
2. P | Q7Q7R8 | Neuropeptide F | 1.43e-02 | 2.33e-03 | NA |
2. P | P55206 | C-type natriuretic peptide | 7.42e-03 | 4.46e-02 | NA |
2. P | Q9LMY9 | Phytosulfokines 1 | 3.94e-04 | 3.87e-05 | NA |
2. P | P0CU94 | Secreted RxLR effector protein 7 | 8.02e-04 | 1.37e-06 | NA |
2. P | E2A1R1 | Allatotropin | 1.11e-02 | 3.59e-05 | NA |
2. P | P01298 | Pancreatic prohormone | 1.17e-02 | 4.89e-03 | NA |
2. P | A0A125S9D9 | Conotoxin Im22.1 | 5.60e-02 | 8.36e-03 | NA |
2. P | G4NBL6 | Host transcription reprogramming factor 10 | 5.04e-01 | 1.49e-02 | NA |
2. P | P50723 | Hyphancin-3G | 5.62e-03 | 8.99e-05 | NA |
2. P | Q8QFQ5 | Brevinin-1Pb | 2.31e-03 | 4.87e-02 | NA |
2. P | Q9Y0X4 | Bradykinin-potentiating peptide BmKbpp | 8.05e-03 | 3.89e-03 | NA |
2. P | P0DTR7 | Apolipoprotein C-I, basic form | 2.66e-04 | 3.50e-07 | NA |
2. P | S0F207 | Omega/kappa-hexatoxin-Hv1g | 1.05e-02 | 9.31e-03 | NA |
2. P | P34929 | Apolipoprotein C-I, basic form | 2.11e-03 | 4.32e-07 | NA |
2. P | M0R8L2 | Spexin | 3.96e-02 | 2.13e-05 | NA |
2. P | P0DSK2 | M-poneratoxin-Dq4e | 2.05e-03 | 7.88e-05 | NA |
2. P | O61272 | Cecropin-A1 | 7.69e-04 | 3.39e-07 | NA |
2. P | Q5WR01 | Opiscorpine-2 | 5.70e-02 | 1.46e-02 | NA |
2. P | P26917 | Somatostatin | 2.84e-03 | 1.50e-03 | NA |
2. P | C3RT23 | Rugosin-LK1 | 2.17e-04 | 2.06e-03 | NA |
2. P | C0HJZ7 | Ocellatin-PT2 | 8.42e-04 | 1.96e-03 | NA |
2. P | B5X8I6 | Neuropeptide-like protein C4orf48 homolog | 1.97e-04 | 3.27e-04 | NA |
2. P | Q8LA14 | Putative phytosulfokines 6 | 3.48e-02 | 3.15e-08 | NA |
2. P | P31107 | Dermaseptin-B2 | 3.66e-04 | 2.21e-04 | NA |
2. P | P48756 | Gastric inhibitory polypeptide | 7.78e-04 | 1.54e-03 | NA |
2. P | P80282 | Dermaseptin-B1 | 9.75e-04 | 1.06e-04 | NA |
2. P | P28672 | Pro-neuropeptide Y | 2.72e-02 | 4.21e-04 | NA |
2. P | P84597 | Dermaseptin-H1 | 5.48e-04 | 1.28e-04 | NA |
2. P | P09929 | Pigment-dispersing hormone peptides | 8.24e-04 | 3.28e-03 | NA |
2. P | D2Y2N5 | U3-theraphotoxin-Hhn1g | 3.71e-02 | 2.72e-03 | NA |
2. P | Q09367 | Neuropeptide-like peptide 11 | 8.73e-04 | 4.10e-04 | NA |
2. P | Q5RDP6 | Matrix Gla protein | 1.66e-02 | 1.83e-03 | NA |
2. P | Q21175 | Chondroitin proteoglycan 8 | 4.34e-03 | 2.23e-03 | NA |
2. P | E1B242 | Esculentin-2MT2 | 2.95e-04 | 2.47e-03 | NA |
2. P | Q5DVA6 | Phylloxin-S1 | 1.97e-04 | 4.68e-02 | NA |
2. P | B5LUQ3 | Preprofallaxidin-2 | 3.64e-05 | 2.49e-03 | NA |
2. P | Q9CR53 | Neuromedin-B | 1.18e-02 | 6.14e-06 | NA |
2. P | Q765I1 | Urotensin-2B | 3.60e-03 | 5.88e-05 | NA |
2. P | B2ZBA0 | Drosulfakinins | 3.12e-02 | 2.40e-02 | NA |
2. P | Q920H1 | Secretoglobin family 3A member 2 | 1.22e-02 | 1.21e-04 | NA |
2. P | P07808 | Pro-neuropeptide Y | 1.46e-02 | 4.13e-04 | NA |
2. P | A0A193H396 | Cruzioseptin-6 | 6.69e-05 | 1.66e-04 | NA |
2. P | P48098 | Peptide YY-like | 3.05e-03 | 1.10e-05 | NA |
2. P | P0DTT4 | Apolipoprotein C-I | 1.22e-04 | 1.94e-04 | NA |
2. P | P91964 | Pigment-dispersing hormone type 2 | 1.07e-04 | 2.20e-02 | NA |
2. P | Q9XYR5 | Contulakin-G | 1.23e-02 | 6.35e-05 | NA |
2. P | P83084 | Maximins 5/H4 type 1 | 1.30e-03 | 2.93e-02 | NA |
2. P | P0DM27 | Conorfamide-Tx2 | 2.28e-02 | 4.84e-06 | NA |
2. P | P33738 | Accessory gland-specific peptide 26Ab | 8.32e-02 | 8.16e-07 | NA |
2. P | Q9PW68 | Pro-neuropeptide Y | 1.35e-02 | 9.07e-05 | NA |
2. P | Q58T93 | Maximins y/H16 | 3.06e-03 | 2.08e-03 | NA |
2. P | P67791 | Cecropin-B | 1.57e-03 | 6.10e-07 | NA |
2. P | D2Y2M0 | U3-theraphotoxin-Hhn1q | 2.64e-02 | 1.09e-02 | NA |
2. P | P06799 | Interferon alpha-7 | 8.04e-04 | 4.26e-02 | NA |
2. P | P91793 | Defensin-A | 4.17e-02 | 2.74e-03 | NA |
2. P | Q8T0Y7 | Neuropeptides CP2 | 6.36e-02 | 1.92e-05 | NA |
2. P | Q9IA10 | Progonadoliberin-1 | 2.05e-02 | 3.47e-07 | NA |
2. P | A0A0D1EAR7 | Secreted effector PIT2 | 3.10e-02 | 5.79e-03 | NA |
2. P | P60041 | Somatostatin | 3.44e-03 | 3.42e-03 | NA |
2. P | C0HL91 | Adipokinetic prohormone type 1 | 1.33e-03 | 7.18e-09 | NA |
2. P | A8WU84 | FMRFamide-like neuropeptides 27 | 2.28e-02 | 4.33e-08 | NA |
2. P | P24512 | Chorion protein S16 | 2.56e-03 | 1.08e-06 | NA |
2. P | P09040 | Drosulfakinins | 2.14e-02 | 1.74e-02 | NA |
2. P | D2Y2N1 | U3-theraphotoxin-Hhn1a 18 | 1.16e-02 | 2.34e-02 | NA |
2. P | D9U2B5 | Bradykinin-potentiating peptide NDBP6 | 7.67e-03 | 1.81e-03 | NA |
2. P | A0A0D9S1R9 | Apolipoprotein C-II | 1.87e-03 | 6.14e-03 | NA |
2. P | Q5G864 | Alpha-defensin 25 | 1.88e-02 | 7.88e-03 | NA |
2. P | P04142 | Cecropin-B | 9.32e-03 | 1.36e-03 | NA |
2. P | P06518 | Abdominal ganglion neuropeptide L11 | 2.31e-02 | 6.35e-03 | NA |
2. P | O93223 | Dermaseptin-A3 | 1.11e-03 | 1.33e-07 | NA |
2. P | D2Y493 | Conotoxin Cal6.3a | 2.56e-02 | 8.86e-03 | NA |
2. P | P42634 | Prosialokinin | 1.26e-02 | 6.14e-06 | NA |
2. P | Q8MUF3 | Cecropin-C | 1.49e-02 | 1.76e-06 | NA |
2. P | P27114 | Promotilin | 8.78e-03 | 2.48e-02 | NA |
2. P | O54713 | Progonadoliberin-1 | 2.92e-03 | 2.55e-09 | NA |
2. P | E2IH92 | Penaeidin-3 | 4.20e-02 | 4.29e-02 | NA |
2. P | O73812 | Progonadoliberin-1 | 9.19e-02 | 9.14e-07 | NA |
2. P | Q6PN81 | Conotoxin Lp5.1 | 1.81e-02 | 2.42e-02 | NA |
2. P | Q7S163 | UPF0499 protein NCU07353 | 9.23e-01 | 6.78e-03 | NA |
2. P | P0DMG0 | Peptide Ctri9819 | 3.41e-04 | 2.33e-03 | NA |
2. P | P41675 | Uncharacterized 7.2 kDa protein in HE65-PK2 intergenic region | NA | 9.54e-03 | NA |
2. P | Q6JQN2 | Peptide BmKn2 | 2.17e-03 | 1.44e-02 | NA |
2. P | C9X4J1 | Anionic peptide | 3.00e-03 | 4.00e-02 | NA |
2. P | P61855 | Adipokinetic hormone | 6.65e-03 | 5.15e-11 | NA |
2. P | B1NWS1 | N.vectensis toxin 1 2 | 1.52e-02 | 3.76e-03 | NA |
2. P | O24618 | CLAVATA3/ESR (CLE)-related protein 2-B | 3.81e-02 | 1.49e-02 | NA |
2. P | Q9XSW6 | Pro-neuropeptide Y | 1.55e-02 | 4.56e-05 | NA |
2. P | Q8UW81 | Progonadoliberin-2 | 3.75e-02 | 2.18e-05 | NA |
2. P | P61110 | Kidney androgen-regulated protein | 1.10e-02 | 1.84e-04 | NA |
2. P | I0DEB3 | Amphipathic peptide CT1 | 5.12e-03 | 4.79e-02 | NA |
2. P | P0DUS6 | DELTA-limacoditoxin(2)-Dv12 | NA | 3.08e-05 | NA |
2. P | O95969 | Secretoglobin family 1D member 2 | 4.50e-03 | 3.76e-03 | NA |
2. P | P86188 | Raniseptin-8 | 5.33e-04 | 1.46e-03 | NA |
2. P | P82268 | Brevinin-2Ta | 1.68e-03 | 2.66e-02 | NA |
2. P | P79155 | Interleukin-4 | 1.90e-03 | 9.94e-03 | NA |
2. P | A0JNP2 | Secretoglobin family 1D member | 2.49e-03 | 4.02e-05 | NA |
2. P | O97686 | Progonadoliberin-2 | 4.23e-02 | 1.31e-03 | NA |
2. P | E2AX75 | Pigment-dispersing hormone peptides | 4.18e-03 | 2.49e-06 | NA |
2. P | Q16661 | Guanylate cyclase activator 2B | 1.14e-02 | 9.31e-04 | NA |
2. P | Q16RI5 | Adipokinetic hormone/corazonin-related peptide | NA | 2.24e-05 | NA |
2. P | Q0Q4F1 | Non-structural protein 3a | NA | 2.84e-07 | NA |
2. P | A0A125S9G3 | Conotoxin Im6.10 | 1.67e-02 | 1.79e-02 | NA |
2. P | P0DN36 | Apolipoprotein A-II | 2.64e-05 | 1.17e-05 | NA |
2. P | P24510 | Chorion protein S16 | 2.01e-02 | 2.09e-05 | NA |
2. P | P10891 | Phormicin | 1.93e-01 | 5.66e-04 | NA |
2. P | Q99MP3 | Calcitonin gene-related peptide 2 | 1.16e-03 | 1.85e-02 | NA |
2. P | E2E4E4 | Cholecystoxin | 3.69e-03 | 3.87e-05 | NA |
2. P | Q3ECD6 | CLAVATA3/ESR (CLE)-related protein 1 | 1.88e-04 | 9.62e-03 | NA |
2. P | Q1EN11 | Dermaseptin-S13 | 1.83e-04 | 1.47e-06 | NA |
2. P | P37042 | Progonadoliberin-1 | 1.41e-03 | 3.21e-06 | NA |
2. P | D0NS57 | RxLR effector protein PITG_15972 | 1.53e-02 | 2.19e-04 | NA |
2. P | Q8UW82 | Progonadoliberin-3 | 6.78e-02 | 5.88e-03 | NA |
2. P | P0DKV7 | Apolipoprotein C-II | 4.61e-04 | 6.71e-04 | NA |
2. P | Q09982 | Neuropeptide-like protein 32 | 8.60e-02 | 3.28e-02 | NA |
2. P | Q805D5 | C-type natriuretic peptide 2 | 1.01e-01 | 5.55e-03 | NA |
2. P | Q1ELU3 | M-zodatoxin-Lt3a | 4.17e-03 | 4.91e-04 | NA |
2. P | D6C4H5 | Conotoxin Cl1.1 | 3.47e-02 | 4.73e-03 | NA |
2. P | Q9SZG4 | Putative phytosulfokines 4 | 2.26e-02 | 7.35e-07 | NA |
2. P | C8AW45 | Interferon gamma-related | 4.89e-03 | 1.12e-03 | NA |
2. P | P0DQG0 | U-scoloptoxin(24)-Er2a | 1.81e-02 | 1.79e-02 | NA |
2. P | Q4RU86 | Protein ALKAL-like | 9.04e-03 | 4.82e-04 | NA |
2. P | Q2UXR2 | Lividin-3 | 1.66e-03 | 2.63e-03 | NA |
2. P | Q8JHE1 | Maximins 3/H5 | 5.36e-04 | 3.44e-02 | NA |
2. P | W4VSM1 | Conotoxin F_Vc1 | 1.61e-03 | 6.78e-03 | NA |
2. P | Q76LU6 | Interleukin-21 | 8.01e-03 | 7.63e-03 | NA |
2. P | P0DKW0 | Apolipoprotein C-II | 4.59e-04 | 1.34e-05 | NA |
2. P | Q5Y4Y1 | U2-agatoxin-Ao1e | 9.43e-04 | 1.21e-02 | NA |
2. P | Q58M18 | Interleukin-4 | 2.31e-03 | 3.46e-02 | NA |
2. P | Q95335 | Progonadoliberin-1 | 7.01e-03 | 1.06e-07 | NA |
2. P | O62690 | Pro-MCH (Fragment) | 1.76e-03 | 4.26e-02 | NA |
2. P | P01303 | Pro-neuropeptide Y | 8.80e-03 | 4.56e-05 | NA |
2. P | W4VSG7 | Conotoxin Vc1 | 2.28e-02 | 1.08e-04 | NA |
2. P | B9TQX3 | Unique cartilage matrix-associated protein | 2.52e-04 | 3.92e-03 | NA |
2. P | P83057 | Kininogen-2 | 5.03e-02 | 3.96e-02 | NA |
2. P | P0DJ03 | Peptide Hp1035 | 5.41e-03 | 1.64e-02 | NA |
2. P | A2Z139 | Uncharacterized protein OsI_030282 | 2.01e-03 | 4.68e-02 | NA |
2. P | P33094 | Somatostatin | 3.32e-04 | 2.19e-03 | NA |
2. P | A6YB85 | Alpha-defensin 1 | 2.23e-02 | 1.87e-02 | NA |
2. P | F1T155 | Brevinin-2ISc | 1.55e-03 | 1.93e-03 | NA |
2. P | Q9Y0X9 | Cecropin-C type 1 | 8.28e-04 | 2.50e-02 | NA |
2. P | P0DME9 | Peptide Hp1412 | 6.27e-03 | 4.82e-04 | NA |
2. P | P20968 | C-type natriuretic peptide 1 | 3.08e-03 | 5.79e-03 | NA |
2. P | Q04745 | Interleukin-4 | 2.05e-03 | 4.22e-02 | NA |
2. P | A0A096P2H4 | Apolipoprotein C-II | 2.03e-03 | 3.48e-04 | NA |
2. P | D2Y2G8 | U3-theraphotoxin-Hhn1o | 4.62e-02 | 1.84e-03 | NA |
2. P | Q65C83 | Uteroglobin | 1.31e-03 | 1.96e-03 | NA |
2. P | G5EI17 | Secreted virulence factor MC69 | 1.82e-01 | 1.74e-04 | NA |
2. P | A0A077DF94 | Spexin prohormone 2 (Fragment) | 8.08e-03 | 6.35e-03 | NA |
2. P | P0DML6 | Apolipoprotein C-IV | 2.99e-03 | 1.45e-03 | NA |
2. P | P0C8U8 | Alpha-conotoxin-like Pu1.4 | 1.60e-02 | 3.24e-04 | NA |
2. P | Q9XT35 | Parathyroid hormone | 9.74e-04 | 8.31e-09 | NA |
2. P | Q7T3K7 | Dermaseptin-S8 | 1.51e-03 | 3.04e-04 | NA |
2. P | P13562 | Progonadoliberin-1 | 3.63e-03 | 3.87e-05 | NA |
2. P | P0DQA9 | U-scoloptoxin(13)-Er1a | 8.25e-02 | 1.79e-02 | NA |
2. P | Q9EPS2 | Peptide YY | 1.85e-02 | 2.54e-02 | NA |
2. P | P0DPM0 | Alpha-conotoxin-like Sm1.2 | 1.25e-01 | 4.23e-03 | NA |
2. P | P0DTG7 | Apolipoprotein C-I | 2.41e-03 | 7.06e-06 | NA |
2. P | P29233 | Sensorin-A | 2.65e-02 | 6.29e-03 | NA |
2. P | Q2M7X4 | Uncharacterized protein YicS | 5.90e-02 | 1.69e-02 | NA |
2. P | B3IXK1 | Interferon gamma | 1.24e-03 | 3.72e-02 | NA |
2. P | P0DKW3 | Apolipoprotein C-IV | 2.33e-03 | 3.40e-08 | NA |
2. P | P50145 | Cholecystokinin B | 2.36e-02 | 3.30e-06 | NA |
2. P | Q8R5G8 | Guanylate cyclase activator 2B | 3.89e-02 | 2.01e-04 | NA |
2. P | Q61268 | Apolipoprotein C-IV | 9.67e-04 | 2.79e-03 | NA |
2. P | Q9TUI9 | Apelin | 1.68e-03 | 2.93e-02 | NA |
2. P | O42471 | Progonadoliberin IIB | 7.14e-02 | 6.85e-06 | NA |
2. P | G0W2H9 | U-actitoxin-Bgr3b | 1.20e-01 | 3.69e-02 | NA |
2. P | Q86N75 | Pro-corazonin | 3.26e-02 | 6.08e-03 | NA |
2. P | W2RE78 | RxLR effector protein 4 | 2.65e-02 | 4.21e-04 | NA |
2. P | D4A540 | Augurin | 2.32e-02 | 3.12e-03 | NA |
2. P | S0F1M6 | Omega/kappa-hexatoxin-Ar1g | 1.29e-01 | 9.31e-03 | NA |
2. P | C7C1L2 | Probable antimicrobial peptide Con13 | 2.24e-06 | 1.17e-02 | NA |
2. P | P0DM82 | Apolipoprotein C-I | 2.33e-05 | 3.30e-06 | NA |
2. P | Q3YEG3 | Conotoxin MiK42 | 7.02e-04 | 1.09e-02 | NA |
2. P | P55090 | Urocortin | 7.03e-04 | 1.53e-07 | NA |
2. P | Q2V4D5 | Putative defensin-like protein 36 | 3.36e-01 | 4.81e-03 | NA |
2. P | Q8T9R8 | Stomoxyn | 2.35e-03 | 3.78e-02 | NA |
2. P | P55099 | Tachykinin-3 | 6.17e-02 | 1.15e-04 | NA |
2. P | P0DMN9 | Apolipoprotein C-II | 2.22e-03 | 2.75e-04 | NA |
2. P | P02779 | Uteroglobin | 1.53e-02 | 4.46e-09 | NA |
2. P | P0CAZ6 | M-zodatoxin-Lt8m | 1.16e-02 | 2.35e-03 | NA |
2. P | P0DTH3 | Apolipoprotein C-IV | 1.07e-03 | 6.11e-05 | NA |
2. P | A0A0P1AK67 | Secreted RxLR effector protein RXLR-C22 | 3.19e-04 | 4.32e-02 | NA |
2. P | Q8R448 | Otospiralin | 2.82e-02 | 2.60e-10 | NA |
2. P | P0DTQ5 | Apolipoprotein C-II | 1.61e-03 | 3.25e-07 | NA |
2. P | Q06589 | Cecropin-1 | 8.48e-04 | 2.96e-06 | NA |
2. P | Q5Y4Y3 | U2-agatoxin-Ao1c | 8.27e-03 | 2.82e-02 | NA |
2. P | D2Y2M2 | U3-theraphotoxin-Hhn1b | 2.26e-02 | 4.83e-02 | NA |
2. P | Q2V4F3 | Defensin-like protein 35 | 6.15e-02 | 1.47e-03 | NA |
2. P | Q8MKG2 | Uteroglobin | 6.73e-03 | 2.82e-05 | NA |
2. P | D5KXG7 | Turripeptide IX-07 | 5.34e-02 | 2.12e-03 | NA |
2. P | Q83IY9 | Uncharacterized protein YicS | 7.57e-02 | 1.15e-02 | NA |
2. P | Q1JS87 | Esculentin-1Vb | 9.18e-04 | 6.83e-04 | NA |
2. P | O36359 | Uncharacterized gene A4 protein | NA | 1.61e-02 | NA |
2. P | Q805E8 | Brain natriuretic peptide | 5.35e-03 | 3.30e-02 | NA |
2. P | Q9UHF0 | Tachykinin-3 | 4.34e-03 | 5.18e-04 | NA |
2. P | P0DP86 | Apolipoprotein A-II | 5.24e-04 | 7.96e-08 | NA |
2. P | P10997 | Islet amyloid polypeptide | 1.89e-02 | 4.86e-04 | NA |
2. P | P10092 | Calcitonin gene-related peptide 2 | 9.03e-04 | 4.93e-03 | NA |
2. P | B3IWF7 | Calcitonin receptor-stimulating peptide 1 | 1.56e-03 | 1.54e-03 | NA |
2. P | P0C846 | Turripeptide Gsg9.1 | 6.20e-02 | 4.22e-02 | NA |
2. P | P82744 | Putative defensin-like protein 131 | 4.99e-03 | 1.60e-02 | NA |
2. P | P18659 | Apolipoprotein C-III | 4.50e-04 | 3.12e-03 | NA |
2. P | V5N6J4 | U-scoloptoxin(15)-Ssm2a | 1.59e-01 | 2.48e-02 | NA |
2. P | P24771 | Protein B9 | NA | 2.95e-02 | NA |
2. P | P06307 | Cholecystokinin | 1.45e-03 | 1.38e-04 | NA |
2. P | P13205 | Natriuretic peptides B | 2.42e-03 | 1.04e-02 | NA |
2. P | Q23247 | Uncharacterized protein ZC168.2 | 2.88e-02 | 2.16e-02 | NA |
2. P | Q9BP59 | Conotoxin VnMSGL-0123 | 3.85e-02 | 1.23e-02 | NA |
2. P | Q3YEE2 | Conotoxin CaHr91 | 9.62e-04 | 3.28e-03 | NA |
2. P | O42241 | Progonadoliberin-2 | 8.03e-03 | 7.13e-06 | NA |
2. P | P0CAZ7 | M-zodatoxin-Lt8o | 6.18e-03 | 1.46e-03 | NA |
2. P | P01269 | Parathyroid hormone | 4.18e-04 | 1.39e-09 | NA |
2. P | A0A090XA85 | Evasin P1104 | 3.55e-02 | 2.88e-02 | NA |
2. P | A8B5P7 | Pleurain-A3 | 8.06e-03 | 1.56e-03 | NA |
2. P | P0CD95 | Uncharacterized protein C17orf67 homolog | 1.64e-04 | 1.65e-12 | NA |
2. P | P51694 | Peptide YY | 2.77e-02 | 2.35e-05 | NA |
2. P | Q9NGP0 | Crustacean hyperglycemic hormones B | 1.19e-01 | 1.46e-02 | NA |
2. P | P0DM93 | Apolipoprotein A-II | 2.03e-04 | 7.13e-07 | NA |
2. P | P0DP50 | Apolipoprotein A-II | 2.73e-04 | 4.69e-06 | NA |
2. P | P81417 | Cecropin-A1 | 1.12e-03 | 2.93e-02 | NA |
2. P | A0A2U8JCR5 | Dermaseptin-PH | 8.60e-05 | 1.54e-02 | NA |
2. P | P0DTG6 | Apolipoprotein C-I | 1.32e-03 | 3.54e-03 | NA |
2. P | Q9PT98 | Peptide Y | 1.70e-02 | 4.32e-07 | NA |
2. P | P07480 | Galanin peptides | 7.56e-03 | 5.79e-07 | NA |
2. P | P82290 | Cecropin-A | 6.14e-04 | 2.49e-04 | NA |
2. P | P18829 | Adipokinetic prohormone type 1 | 1.27e-03 | 5.19e-06 | NA |
2. P | P15743 | Parathyroid hormone | 9.47e-04 | 4.65e-07 | NA |
2. P | Q0VZ41 | Phylloseptin-H6 | 4.83e-04 | 3.10e-02 | NA |
2. P | P86039 | Raniseptin-6 | 1.12e-04 | 2.15e-04 | NA |
2. P | Q9NJC6 | Potassium channel toxin BmTXK-beta | 6.52e-04 | 2.82e-02 | NA |
2. P | Q9VDH4 | Protein Turandot B | 3.01e-03 | 1.71e-02 | NA |
2. P | P55208 | C-type natriuretic peptide prohormone | 1.60e-03 | 3.63e-03 | NA |
2. P | P20394 | Exendin-3 | 5.96e-03 | 2.64e-05 | NA |
2. P | O46199 | Accessory gland protein Acp53Ea | 4.58e-04 | 7.82e-03 | NA |
2. P | O97655 | Progonadoliberin-2 | 1.21e-02 | 4.06e-03 | NA |
2. P | P0DUS1 | Peptide Hact-1 | NA | 1.71e-03 | NA |
2. P | Q91V13 | Liver-expressed antimicrobial peptide 2 | 4.31e-02 | 1.22e-02 | NA |
2. P | Q9FS10 | Phytosulfokines | 6.44e-02 | 2.26e-05 | NA |
2. P | D2HJ50 | Uncharacterized protein C11orf94 homolog | 6.17e-02 | 2.30e-02 | NA |
2. P | D2Y213 | U4-theraphotoxin-Hhn1aa | 8.91e-05 | 4.72e-02 | NA |
2. P | P01270 | Parathyroid hormone | 1.67e-03 | 1.67e-09 | NA |
2. P | Q99N14 | Tachykinin-4 | 1.85e-01 | 1.03e-03 | NA |
2. P | P06303 | Pancreatic prohormone | 1.61e-02 | 8.86e-07 | NA |
2. P | P08379 | Adipokinetic prohormone type 2 | 2.97e-02 | 8.52e-06 | NA |
2. P | Q8JFY4 | Ghrelin | 3.25e-02 | 2.47e-09 | NA |
2. P | Q8I6S2 | Tachykinin-2 | 1.10e-04 | 1.91e-03 | NA |
2. P | F1QQI2 | Spexin prohormone 1 | 5.62e-04 | 5.00e-09 | NA |
2. P | P0DM94 | Apolipoprotein A-II | 3.44e-04 | 6.23e-07 | NA |
2. P | Q58T95 | Maximins y/H11 | 3.10e-04 | 4.12e-02 | NA |
2. P | P35543 | Serum amyloid A-3 protein | 1.99e-03 | 1.74e-02 | NA |
2. P | Q800R2 | Caerin-1.1 | 7.62e-04 | 2.17e-03 | NA |
2. P | Q76LU5 | Interleukin-21 | 3.57e-02 | 5.64e-03 | NA |
2. P | Q9R0R3 | Apelin | 1.73e-01 | 7.44e-03 | NA |
2. P | P33715 | Urotensin-2 | 2.51e-02 | 1.37e-04 | NA |
2. P | D2Y246 | U3-theraphotoxin-Hhn1l | 1.11e-01 | 1.14e-02 | NA |
2. P | Q9BT56 | Spexin | 2.83e-03 | 5.85e-07 | NA |
2. P | P0CV00 | Secreted RxLR effector protein 21 | 1.65e-02 | 1.29e-04 | NA |
2. P | Q8WSV2 | Andropin | 5.16e-05 | 1.14e-03 | NA |
2. P | Q2VPS3 | Uteroglobin | 6.13e-03 | 1.06e-05 | NA |
2. P | L0GBQ6 | Antimicrobial peptide Con22 | 1.75e-06 | 2.80e-04 | NA |
2. P | P11684 | Uteroglobin | 3.31e-03 | 3.95e-04 | NA |
2. P | P33439 | Progonadoliberin-1 | 4.47e-03 | 2.02e-07 | NA |
2. P | P0DKV9 | Apolipoprotein C-II | 9.80e-04 | 9.96e-05 | NA |
2. P | P0DPG8 | Apolipoprotein C-I | 1.23e-03 | 2.37e-05 | NA |
2. P | P20727 | Serum amyloid A-2 protein | 1.06e-03 | 3.58e-02 | NA |
2. P | P21663 | Andropin | 1.03e-04 | 1.22e-02 | NA |
2. P | Q9XVX1 | FMRFamide-like neuropeptides 19 | 2.34e-03 | 5.94e-08 | NA |
2. P | I0B6F3 | Chassatide C4 | 7.01e-03 | 2.50e-02 | NA |
2. P | Q9I8P3 | Pro-neuropeptide Y | 7.48e-03 | 1.50e-03 | NA |
2. P | P36192 | Defensin | 1.49e-01 | 1.23e-02 | NA |
2. P | P0DPE6 | Toxin CjTL8 | 1.48e-01 | 2.56e-03 | NA |
2. P | O08987 | Interleukin-5 | 1.39e-04 | 9.23e-03 | NA |
2. P | A8R0V4 | Exocrine gland-secreted peptide 22 | 5.72e-03 | 3.14e-03 | NA |
2. P | P84225 | Cecropin-C | 1.52e-03 | 4.10e-07 | NA |
2. P | Q21156 | FMRFamide-like neuropeptides 11 | 3.50e-03 | 1.23e-02 | NA |
2. P | P01356 | Cholecystokinin | 3.68e-03 | 3.68e-04 | NA |
2. P | A0A144LUY5 | Centrocin 1 | 1.47e-03 | 1.49e-02 | NA |
2. P | O17513 | Ceratotoxin-D | 4.32e-03 | 9.96e-05 | NA |
2. P | P84567 | Phylloseptin-H2 | 1.76e-03 | 1.79e-02 | NA |
2. P | G4ZBI3 | RxLR effector protein Avh238 | 3.77e-03 | 1.11e-06 | NA |
2. P | Q9XT91 | Interleukin-5 | 1.27e-03 | 4.72e-02 | NA |
2. P | P85798 | Prohormone-1 | 9.39e-05 | 1.22e-04 | NA |
2. P | P0DMP0 | Apolipoprotein C-I | 4.53e-03 | 1.56e-05 | NA |
2. P | P81602 | Defensin-B | 1.88e-02 | 2.10e-03 | NA |
2. P | Q52MQ7 | Keratinocyte differentiation-associated protein | 6.77e-02 | 2.79e-08 | NA |
2. P | Q9YGH3 | Somatostatin-1B | 4.73e-03 | 2.11e-04 | NA |
2. P | B3H5A9 | Precursor of CEP6 | 2.04e-02 | 1.25e-03 | NA |
2. P | P0DQF2 | U-scoloptoxin(21)-Sm1a | 6.64e-02 | 3.01e-03 | NA |
2. P | Q800Y2 | Matrix Gla protein | 2.05e-01 | 1.45e-02 | NA |
2. P | C0HKV8 | Neuropeptide SIFamide | 1.70e-05 | 3.02e-07 | NA |
2. P | C0HKQ8 | Cecropin-A2 | 1.50e-03 | 1.17e-06 | NA |
2. P | Q75V93 | Calcitonin receptor-stimulating peptide 2 | 1.26e-03 | 4.06e-04 | NA |
2. P | Q5Y4W2 | U2-agatoxin-Ao1z | 1.01e-02 | 1.76e-02 | NA |
2. P | P02820 | Osteocalcin | 1.59e-02 | 3.01e-03 | NA |
2. P | P10631 | Peptide YY | 8.11e-03 | 6.78e-03 | NA |
2. P | G1FR37 | RxLR effector protein Avh52 | 1.57e-03 | 1.80e-03 | NA |
2. P | P01360 | Atrial gland and califin peptides | 4.32e-02 | 2.15e-03 | NA |
2. P | P01581 | Interferon gamma | 7.73e-03 | 4.85e-03 | NA |
2. P | P48757 | Gastrin | 1.91e-02 | 3.88e-04 | NA |
2. P | D0N0J7 | RxLR effector protein SFI1 | 8.89e-03 | 4.89e-09 | NA |
2. P | Q27023 | Tenecin-1 | 9.44e-02 | 5.93e-03 | NA |
2. P | P13438 | Trophoblast-specific protein alpha | 1.41e-02 | 2.99e-05 | NA |
2. P | D2Y2N9 | Hainantoxin-XVIII-5 | 1.63e-01 | 4.09e-02 | NA |
2. P | F6JWV0 | Conotoxin Lt28.4 | 1.60e-02 | 4.26e-02 | NA |
2. P | P21005 | Protein B9 | NA | 2.32e-02 | NA |
2. P | P0DML4 | Apolipoprotein C-IV | 3.18e-03 | 1.41e-05 | NA |
2. P | Q6UGQ3 | Secretoglobin family 2B member 2 | 4.40e-03 | 2.58e-03 | NA |
2. P | Q9IA08 | Progonadoliberin-2 | 6.61e-03 | 3.25e-09 | NA |
2. P | P12969 | Islet amyloid polypeptide | 2.51e-02 | 2.99e-06 | NA |
2. P | Q9BJW0 | Omega-hexatoxin-Hi2b | 6.56e-03 | 4.72e-02 | NA |
2. P | P01268 | Parathyroid hormone | 1.78e-03 | 5.27e-08 | NA |
2. P | D0MXE4 | RxLR effector protein PITG_02860 | 2.71e-02 | 4.38e-03 | NA |
2. P | A0AEI6 | Brevinin-2GHc | 5.59e-05 | 1.92e-04 | NA |
2. P | C0HJZ8 | Ocellatin-PT3 | 1.27e-04 | 1.56e-03 | NA |
2. P | Q1JS92 | Ranatuerin-2Va | 3.70e-03 | 1.29e-02 | NA |
2. P | O16825 | Andropin | 1.59e-04 | 4.86e-04 | NA |
2. P | Q3T146 | Uncharacterized protein C5orf46 homolog | 5.82e-04 | 1.29e-08 | NA |
2. P | P0C8W1 | Non-disulfide-bridged peptide 5.5 | 2.67e-03 | 1.02e-03 | NA |
2. P | D2Y251 | Hainantoxin-XVIII | 1.28e-01 | 1.46e-02 | NA |
2. P | Q4LCT1 | Toxin-like peptide AaF1CA7 | 3.61e-02 | 3.09e-03 | NA |
2. P | F1T153 | Brevinin-2ISa | 7.01e-04 | 6.65e-04 | NA |
2. P | A0A072V9Z0 | CLAVATA3/ESR (CLE)-related protein 33 | 2.98e-04 | 2.46e-02 | NA |
2. P | B1NWR7 | N.vectensis toxin 1 8 | 3.95e-03 | 2.70e-03 | NA |
2. P | O93225 | Dermaseptin AA-3-4 | 6.40e-05 | 1.20e-03 | NA |
2. P | O93455 | Dermaseptin PD-3-7 | 6.77e-04 | 3.04e-03 | NA |
2. P | Q27441 | Pro-neuropeptide Y | 2.05e-02 | 5.88e-03 | NA |
2. P | P07750 | Interleukin-4 | 2.00e-02 | 4.22e-02 | NA |
2. P | B3P311 | Protein Turandot B2 | 2.52e-03 | 1.77e-04 | NA |
2. P | P0DTG9 | Apolipoprotein C-IV | 1.72e-03 | 7.11e-05 | NA |
2. P | J7H8J4 | Dermaseptin-1 | 2.10e-04 | 1.12e-02 | NA |
2. P | O77515 | Interleukin-5 | 4.32e-04 | 3.30e-02 | NA |
2. P | F6JWU7 | Alpha-conotoxin Lt28.1 | 9.36e-03 | 4.87e-02 | NA |
2. P | P50144 | Cholecystokinin A | 7.20e-03 | 2.11e-07 | NA |
2. P | P23582 | C-type natriuretic peptide | 8.83e-03 | 4.69e-03 | NA |
2. P | A0A5P9K5G4 | Dermaseptin-SP5 | 5.62e-04 | 4.93e-06 | NA |
2. P | E7EKE0 | Brevinin-2HS2A | 9.10e-04 | 7.82e-03 | NA |
2. P | P0DOC1 | Apolipoprotein C-II | 4.00e-04 | 4.49e-03 | NA |
2. P | P0DTR1 | Apolipoprotein A-II | 6.59e-04 | 7.28e-07 | NA |
2. P | Q1JS94 | Palustrin-1c | 1.97e-04 | 6.03e-04 | NA |
2. P | P0DN59 | Teretoxin Tsu11.2 | 5.57e-01 | 1.00e-02 | NA |
2. P | Q9TT95 | Galanin-like peptide | 1.65e-01 | 1.43e-02 | NA |
2. P | P86038 | Raniseptin-3 | 2.89e-04 | 1.35e-04 | NA |
2. P | P09859 | Gastrin/cholecystokinin-like peptide | 1.96e-02 | 2.78e-07 | NA |
2. P | P06759 | Apolipoprotein C-III | 1.75e-04 | 2.35e-03 | NA |
2. P | Q6RUW3 | Pro-neuropeptide Y | 1.33e-02 | 3.08e-05 | NA |
2. P | D2Y241 | U3-theraphotoxin-Hhn1a 2 | 2.79e-02 | 6.56e-03 | NA |
2. P | O97395 | Clavaspirin | 3.86e-04 | 3.55e-04 | NA |
2. P | A0A5J6KCM0 | N.vectensis toxin 5 | NA | 3.28e-02 | NA |
2. P | P82270 | Rhesus theta defensin-1/3 subunit A | 1.94e-03 | 4.06e-02 | NA |
2. P | P02782 | Prostatic steroid-binding protein C1 | 2.61e-03 | 5.67e-06 | NA |
2. P | P14765 | Pro-neuropeptide Y | 4.42e-03 | 5.88e-05 | NA |
2. P | Q5H8A1 | Neuromedin-S | 3.67e-02 | 2.77e-04 | NA |
2. P | P81686 | Cecropin-B | 1.53e-03 | 2.75e-07 | NA |
2. P | P12967 | Islet amyloid polypeptide | 2.46e-02 | 6.73e-03 | NA |
2. P | P69031 | Aurein-5.2 | 1.38e-03 | 2.79e-02 | NA |
2. P | P11384 | Secretin | 1.15e-02 | 1.35e-05 | NA |
2. P | P14956 | Cecropin-B | 5.77e-04 | 7.43e-07 | NA |
2. P | Q05702 | Secretoglobin family 1C member 1 | 2.22e-03 | 1.97e-06 | NA |
2. P | P08376 | Sarcotoxin-1B | 1.46e-03 | 1.01e-05 | NA |
2. P | D0NP16 | RxLR effector protein PITG_14783 | 1.52e-01 | 3.52e-02 | NA |
2. P | P40148 | Osteocalcin | 3.91e-02 | 2.35e-03 | NA |
2. P | P0DQF7 | U-scoloptoxin(23)-Er1a | 3.86e-03 | 2.60e-04 | NA |
2. P | Q8R5G9 | Guanylin | 5.42e-02 | 2.33e-03 | NA |
2. P | O43555 | Progonadoliberin-2 | 1.92e-01 | 2.47e-03 | NA |
2. P | Q0VZ39 | Phylloseptin-H8 | 3.16e-04 | 1.01e-02 | NA |
2. P | Q2UXR3 | Lividin-2 | 3.52e-04 | 2.27e-03 | NA |
2. P | P05011 | Interferon alpha-1 | 9.51e-04 | 1.81e-03 | NA |
2. P | B1P1A9 | U3-theraphotoxin-Cg1c | 2.01e-03 | 2.60e-02 | NA |
2. P | Q9XZH0 | Cecropin-B (Fragment) | 2.03e-03 | 2.13e-07 | NA |
2. P | Q62716 | Neutrophil antibiotic peptide NP-1 | 1.72e-01 | 4.91e-02 | NA |
2. P | A8MRC6 | Protein LURE 1.5 | 9.97e-02 | 1.56e-02 | NA |
2. P | P09916 | Somatoliberin | 2.96e-03 | 4.17e-10 | NA |
2. P | O46688 | Somatostatin | 4.32e-04 | 1.49e-02 | NA |
2. P | Q62715 | Neutrophil antibiotic peptide NP-2 | 1.38e-01 | 2.77e-02 | NA |
2. P | P64460 | Uncharacterized protein YncJ | 3.47e-05 | 3.99e-05 | NA |
2. P | C0HJZ6 | Ocellatin-PT1 | 4.10e-03 | 7.94e-04 | NA |
2. P | P0DOA4 | Apolipoprotein C-I | 1.62e-03 | 1.07e-06 | NA |
2. P | P84226 | Cecropin-C | 2.64e-04 | 4.10e-07 | NA |
2. P | Q68Y23 | M-myrmeciitoxin-Mb1a | 3.50e-03 | 2.42e-02 | NA |
2. P | A9CM07 | M-myrmeciitoxin-Mb3a | 8.69e-04 | 9.31e-03 | NA |
2. P | Q6DUW8 | Protein IDA-LIKE 5 | 5.42e-04 | 2.03e-05 | NA |
2. P | P51919 | Progonadoliberin-1 | 8.91e-02 | 9.16e-05 | NA |
2. P | Q5Y4Y5 | U2-agatoxin-Ao1a | 4.33e-02 | 1.76e-02 | NA |
2. P | P31532 | Serum amyloid A-4 protein | 4.41e-03 | 6.83e-04 | NA |
2. P | D5J9S0 | Natriuretic peptide BF131 | 3.93e-02 | 3.44e-02 | NA |
2. P | P33689 | Pro-neuropeptide Y | 1.32e-02 | 6.23e-05 | NA |
2. P | P0DPV1 | U-scoloptoxin(10)-Ssd2a | 7.92e-04 | 3.93e-02 | NA |
2. P | E2AZE8 | Diuretic hormone class 2 | 9.78e-03 | 5.20e-05 | NA |
2. P | P13684 | Prolevitide | 9.92e-05 | 1.54e-09 | NA |
2. P | Q58T45 | Maximins 10/H3 | 4.32e-04 | 1.34e-02 | NA |
2. P | Q91X13 | Liver-expressed antimicrobial peptide 2 (Fragment) | 1.23e-01 | 3.75e-02 | NA |
2. P | D6WT67 | RYamide neuropeptides | 1.44e-02 | 4.73e-04 | NA |
2. P | P68248 | Pancreatic hormone | 1.45e-02 | 5.88e-03 | NA |
2. P | P50705 | Alpha-defensin 7 | 1.77e-01 | 3.69e-02 | NA |
2. P | F7UI85 | Phylloseptin-S2 | 1.93e-03 | 1.05e-02 | NA |
2. P | Q2V4A3 | Defensin-like protein 293 | 9.32e-03 | 2.68e-02 | NA |
2. P | P0DPG9 | Apolipoprotein C-I | 4.15e-04 | 1.53e-04 | NA |
2. P | W8GNV3 | M-myrmicitoxin(01)-Tb1a | 1.54e-03 | 6.67e-03 | NA |
2. P | Q4VP08 | Protein LURE 1.2 | 6.65e-04 | 1.35e-02 | NA |
2. P | P33680 | Guanylin | 3.51e-02 | 1.29e-03 | NA |
2. P | P0DQB8 | Mu-scoloptoxin(15)-Ssd1a | 1.79e-01 | 7.79e-06 | NA |
2. P | P05009 | Interferon alpha-C | 1.79e-03 | 6.19e-03 | NA |
2. P | Q867W1 | FMRFamide-related neuropeptides | 6.32e-03 | 6.56e-07 | NA |
2. P | C0HL92 | Adipokinetic prohormone type 1 | 9.03e-04 | 1.20e-05 | NA |
2. P | E1AWD4 | Brevinin-1CG1 | 2.23e-03 | 1.31e-03 | NA |
2. P | O96049 | Defensin | 3.66e-02 | 3.20e-02 | NA |
2. P | P56688 | Mandibular organ-inhibiting hormone | 2.80e-02 | 2.73e-02 | NA |
2. P | P01353 | Gastrin | 2.08e-02 | 5.15e-05 | NA |
2. P | A2XAM1 | Uncharacterized protein OsI_009114 | 4.52e-05 | 4.06e-02 | NA |
2. P | D5KXH2 | Turripeptide IX-04 | 2.64e-02 | 3.80e-06 | NA |
2. P | Q90WF4 | Pro-neuropeptide Y | 9.73e-05 | 1.04e-04 | NA |
2. P | Q9GZX6 | Interleukin-22 | 1.30e-02 | 8.86e-03 | NA |
2. P | Q90W22 | Ghrelin | 1.65e-03 | 2.04e-07 | NA |
2. P | Q9W7F0 | Somatostatin-1 | 3.13e-03 | 2.25e-04 | NA |
2. P | Q23971 | Antennal-specific protein OS-C | 2.53e-02 | 1.18e-08 | NA |
2. P | B4I608 | Protein Turandot F | 8.11e-03 | 6.73e-03 | NA |
2. P | Q9W7E9 | Somatostatin-2 | 9.74e-03 | 2.41e-03 | NA |
2. P | Q68Y22 | M-myrmeciitoxin-Mb2a | 8.05e-03 | 2.03e-04 | NA |
2. P | Q58T59 | Maximins 6/H10 | 4.77e-04 | 1.74e-02 | NA |
2. P | P0DMT8 | Apolipoprotein C-I | 1.25e-03 | 1.39e-04 | NA |
2. P | Q9XW71 | Luqin-like RYamide peptides lury-1 | 4.41e-02 | 2.14e-06 | NA |
2. P | P0DN56 | Teretoxin Tsu6.8 | 1.46e-01 | 3.52e-02 | NA |
2. P | P37044 | Progonadoliberin-2 | 2.95e-03 | 4.19e-08 | NA |
2. P | D2Y2M5 | U3-theraphotoxin-Hhn1a 14 | 4.24e-02 | 4.79e-02 | NA |
2. P | P0DJI9 | Serum amyloid A-2 protein | 1.01e-03 | 3.17e-02 | NA |
2. P | P33740 | Accessory gland-specific peptide 26Ab | 1.06e-01 | 4.46e-07 | NA |
2. P | O93451 | Dermatoxin-DA1 | 2.61e-03 | 1.24e-05 | NA |
2. P | Q5I4E6 | Conotoxin Gla-TxX | 5.16e-02 | 2.07e-02 | NA |
2. P | C6EVG2 | Exendin-2-long | 1.32e-03 | 3.21e-04 | NA |
2. P | A0A023PZB3 | Protein FMP49, mitochondrial | 2.43e-03 | 9.51e-05 | NA |
2. P | A0A193H395 | Cruzioseptin-1 | 2.92e-04 | 1.60e-03 | NA |
2. P | A0SN42 | Brevinin-ALb | 3.43e-03 | 1.96e-02 | NA |
2. P | B3IUD8 | Diuretic hormone 41 | 1.15e-02 | 7.25e-03 | NA |
2. P | Q26324 | Red pigment-concentrating prohormone | 4.35e-03 | 1.61e-05 | NA |
2. P | Q963A9 | Cecropin-B type 2 | 5.01e-04 | 1.22e-03 | NA |
2. P | P01301 | Pancreatic prohormone (Fragment) | 4.54e-02 | 2.85e-04 | NA |
2. P | P27916 | Apolipoprotein C-II | 8.76e-04 | 6.97e-05 | NA |
2. P | P69157 | Pro-MCH 2 | 1.19e-01 | 1.64e-05 | NA |
2. P | Q6UXT8 | ALK and LTK ligand 1 | 1.25e-01 | 5.61e-04 | NA |
2. P | P0DTT3 | Apolipoprotein C-I | 9.25e-04 | 1.94e-04 | NA |
2. P | C5J886 | Amphipathic peptide OcyC1 | 1.15e-03 | 6.45e-03 | NA |
2. P | P0DOA2 | Apolipoprotein C-I, basic form | 2.32e-03 | 3.50e-07 | NA |
2. P | P0DTT5 | Apolipoprotein C-I | 2.49e-03 | 1.27e-05 | NA |
2. P | A0A2Y9GES1 | Apolipoprotein A-II | 2.67e-04 | 5.85e-07 | NA |
2. P | P19788 | Matrix Gla protein | 1.74e-02 | 5.56e-05 | NA |
2. P | D0N0I9 | RxLR effector protein PexRD41 | 5.12e-03 | 8.59e-07 | NA |
2. P | P51924 | Progonadoliberin IIA | 2.05e-02 | 7.52e-05 | NA |
2. P | C0HK01 | Ocellatin-PT6 | 3.21e-03 | 7.96e-08 | NA |
2. P | O15981 | Crustacean hyperglycemic hormones 5 | 5.29e-02 | 1.25e-03 | NA |
2. P | P0DKY9 | Conantokin R1-A | 3.40e-03 | 1.55e-02 | NA |
2. P | O77220 | Crustacean hyperglycemic hormones | 6.71e-02 | 4.00e-02 | NA |
2. P | P55885 | Gastrin | 2.49e-02 | 5.83e-05 | NA |
2. P | Q06435 | Interleukin-3 | 1.53e-02 | 1.98e-03 | NA |
2. P | P0DTQ8 | Apolipoprotein C-I | 6.46e-04 | 7.20e-06 | NA |
2. P | Q96PL1 | Secretoglobin family 3A member 2 | 1.22e-02 | 1.90e-02 | NA |
2. P | Q9VU58 | Neuropeptide-like 2 | 4.31e-04 | 6.26e-12 | NA |
2. P | P0CV07 | Secreted RxLR effector protein 38 | 1.23e-02 | 7.44e-03 | NA |
2. P | Q9GL67 | Parathyroid hormone | 1.87e-04 | 4.80e-07 | NA |
2. P | Q14BU0 | Unique cartilage matrix-associated protein | 6.52e-04 | 3.69e-05 | NA |
2. P | P81264 | Prolactin-releasing peptide | 6.16e-03 | 3.84e-02 | NA |
2. P | Q9QYH7 | Appetite-regulating hormone | 1.46e-02 | 1.87e-04 | NA |
2. P | O93221 | Dermatoxin-A1 | 4.58e-04 | 2.61e-05 | NA |
2. P | H2CYR5 | Cytotoxic linear peptide | 1.47e-03 | 2.25e-03 | NA |
2. P | M9P2C1 | Tachykinin-like peptide | 5.61e-04 | 4.97e-03 | NA |
2. P | O77620 | Interleukin-2 | 1.27e-03 | 1.50e-02 | NA |
2. P | B5LUQ6 | Preprofallaxidin-5 | 3.84e-02 | 1.72e-02 | NA |
2. P | Q8MPY9 | FMRFamide-like neuropeptides 26 | 5.17e-02 | 1.86e-06 | NA |
2. P | P0DUQ8 | Conotoxin Pl064 | NA | 4.82e-04 | NA |
2. P | Q11099 | Protein snet-1 | 3.06e-03 | 2.34e-06 | NA |
2. P | P23227 | Developmentally-regulated ectodermal protein | 1.84e-02 | 2.20e-09 | NA |
2. P | P0DTQ7 | Apolipoprotein C-I | 2.71e-03 | 2.56e-05 | NA |
2. P | Q9WVA9 | Pro-FMRFamide-related neuropeptide FF | 1.03e-01 | 1.62e-03 | NA |
2. P | Q2UXR4 | Lividin-1 | 3.97e-03 | 9.78e-03 | NA |
2. P | Q9Y0Y0 | Cecropin-B type 1 | 5.02e-04 | 1.67e-02 | NA |
2. P | P40147 | Osteocalcin | 2.88e-02 | 2.31e-03 | NA |
2. P | P11242 | Galanin peptides | 1.22e-02 | 8.03e-09 | NA |
2. P | P47966 | Interleukin-4 | 3.21e-03 | 2.56e-03 | NA |
2. P | Q9BDX4 | Interleukin-3 | 7.75e-03 | 2.33e-03 | NA |
2. P | O18495 | Styelin-D | 1.59e-03 | 2.11e-02 | NA |
2. P | Q06318 | Uteroglobin | 4.53e-03 | 2.24e-08 | NA |
2. P | P18419 | Seminal vesicle secretory protein 4 | 7.00e-02 | 2.50e-07 | NA |
2. P | P01510 | Cecropin-D | 9.98e-04 | 3.17e-03 | NA |
2. P | A0A0P1AXF0 | Secreted RxLR effector protein RXLR-C06 | 2.99e-03 | 4.97e-03 | NA |
2. P | P0CAY6 | Protein LURE 1.4 | 5.77e-04 | 1.56e-02 | NA |
2. P | D2Y2P2 | Hainantoxin-XVIII.2 | 1.93e-01 | 2.32e-02 | NA |
2. P | Q5Y4X7 | U2-agatoxin-Ao1i | NA | 1.28e-02 | NA |
2. P | P50721 | Hyphancin-3E | 2.11e-03 | 3.23e-03 | NA |
2. P | O77762 | Interleukin-4 | 5.41e-03 | 9.38e-03 | NA |
2. P | Q05020 | Apolipoprotein C-II | 4.83e-04 | 6.95e-04 | NA |
2. P | P75147 | Uncharacterized lipoprotein MPN_650 | 6.89e-03 | 1.72e-02 | NA |
2. P | P04563 | Gastrin | 7.63e-02 | 6.14e-04 | NA |
2. P | P19034 | Apolipoprotein C-II | 5.43e-04 | 6.83e-04 | NA |
2. P | Q3YWE7 | Uncharacterized protein YicS | 6.57e-02 | 1.69e-02 | NA |
2. P | P30367 | Interleukin-4 | 2.28e-03 | 3.63e-03 | NA |
2. P | P0DM95 | Apolipoprotein A-II | 3.60e-04 | 5.54e-09 | NA |
2. P | P52212 | Parathyroid hormone | 1.31e-03 | 8.23e-10 | NA |
2. P | Q5DVA5 | Dermatoxin-S1 | 1.18e-03 | 5.72e-05 | NA |
2. P | Q6PDA7 | Sperm-associated antigen 11A | 5.62e-01 | 1.22e-03 | NA |
2. P | Q9XZG9 | Cecropin-A (Fragment) | 1.64e-02 | 3.82e-03 | NA |
2. P | P12278 | Apolipoprotein C-II | 4.55e-04 | 3.45e-03 | NA |
2. P | A0A096P2H7 | Apolipoprotein C-I, basic form | 2.58e-03 | 4.32e-07 | NA |
2. P | P0DMF5 | Peptide Ctri9194 | 1.22e-02 | 1.07e-04 | NA |
2. P | G5A731 | RxLR effector protein Avh262 | 2.53e-02 | 3.71e-04 | NA |
2. P | Q58T94 | Maximins y/Hv type 2 | 1.10e-03 | 2.31e-03 | NA |
2. P | Q9BEF8 | Appetite-regulating hormone | 2.55e-02 | 2.01e-06 | NA |
2. P | P0DPH4 | Apolipoprotein C-I | 5.33e-04 | 7.11e-05 | NA |
2. P | O81003 | Phytosulfokines 2 | 2.26e-03 | 1.42e-04 | NA |
2. P | O96690 | Protein PDF | 9.72e-04 | 2.50e-07 | NA |
2. P | D2Z1D6 | Pigment-dispersing hormone peptides | 2.39e-04 | 1.17e-03 | NA |
2. P | B4R1Q5 | Protein Turandot A2 | 3.13e-03 | 6.35e-03 | NA |
2. P | Q800S2 | Plasticin-C1 | 3.38e-04 | 1.42e-02 | NA |
2. P | P51921 | Progonadoliberin-3 | 2.85e-03 | 3.46e-02 | NA |
2. P | Q2UXR1 | Lividin-4 | 1.22e-03 | 7.04e-05 | NA |
2. P | P80710 | Clavanin-A | 1.02e-04 | 3.28e-03 | NA |
2. P | Q2V4C4 | Putative defensin-like protein 280 | 3.90e-03 | 2.66e-02 | NA |
2. P | P01169 | Somatostatin-1 | 1.92e-03 | 7.60e-04 | NA |
2. P | F7UI87 | Phylloseptin-S4 | 7.94e-04 | 2.21e-02 | NA |
2. P | P86547 | Osteocalcin-2 | 2.37e-02 | 5.27e-07 | NA |
2. P | Q8MMH5 | Small venom protein 1 | 1.06e-01 | 3.28e-02 | NA |
2. P | O61281 | Cecropin-A2 (Fragment) | 4.62e-04 | 5.59e-03 | NA |
2. P | O16137 | Defensin-2 | 1.54e-01 | 2.40e-04 | NA |
2. P | Q9BP51 | Conotoxin Ar5.1 b | 7.67e-05 | 2.21e-04 | NA |
2. P | P0DUP4 | Apolipoprotein C-II | 1.53e-03 | 8.58e-05 | NA |
2. P | P06833 | Caltrin | 1.24e-02 | 2.74e-03 | NA |
2. P | D3ZKM3 | Protein GPR15L | 1.27e-02 | 1.56e-03 | NA |
2. P | C0HKU0 | Neuropeptide IMFamide | 2.66e-03 | 2.30e-06 | NA |
2. P | P0DP84 | Apolipoprotein A-II | 1.17e-04 | 5.44e-08 | NA |
2. P | D0NZB7 | RxLR effector protein PITG_18683 | 1.39e-01 | 6.33e-06 | NA |
2. P | P0CE38 | Apolipoprotein C-I, basic form | 2.33e-03 | 1.16e-05 | NA |
2. P | P51922 | Progonadoliberin-3 | 9.25e-03 | 3.92e-06 | NA |
2. P | P57774 | Pro-neuropeptide Y | 4.36e-04 | 3.23e-05 | NA |
2. P | P0CI42 | Neurotoxin beta-KTx 14.3 | 4.49e-02 | 2.29e-02 | NA |
2. P | D2Y2N6 | U3-theraphotoxin-Hhn1h | 1.71e-02 | 3.89e-03 | NA |
2. P | P0DM17 | Conotoxin Mr105 | 3.14e-03 | 2.70e-04 | NA |
2. P | Q8MJ39 | Matrix Gla protein | 2.76e-02 | 9.87e-05 | NA |
2. P | Q8I6R2 | Conotoxin Vx2 | 8.37e-02 | 2.18e-02 | NA |
2. P | P0DUE8 | Apolipoprotein C-I | 3.49e-04 | 4.90e-07 | NA |
2. P | P0CAY0 | Putative defensin-like protein 28 | 1.03e-02 | 5.74e-03 | NA |
2. P | Q9IA09 | Progonadoliberin-3 | 1.79e-03 | 4.10e-05 | NA |
2. P | P51925 | Progonadoliberin-2 | 4.56e-02 | 2.61e-08 | NA |
2. P | P0DQJ0 | U-Asilidin(1)-Mar3a | 3.94e-02 | 4.75e-02 | NA |
2. P | P0DTR2 | Apolipoprotein A-II | 3.87e-04 | 7.13e-07 | NA |
2. P | P45653 | Progonadoliberin-3 | 6.62e-02 | 1.32e-07 | NA |
2. P | P0CH46 | N.vectensis toxin 1 5 | 2.14e-02 | 2.70e-03 | NA |
2. P | Q8X4C9 | Uncharacterized protein YicS | 6.52e-02 | 1.29e-02 | NA |
2. P | Q9ULZ1 | Apelin | 3.84e-02 | 3.44e-02 | NA |
2. P | Q8TGJ3 | Protein kish | 5.33e-03 | 4.16e-03 | NA |
2. P | Q8JHB9 | Cholecystokinin-8 | 3.62e-04 | 1.78e-07 | NA |
2. P | P86186 | Raniseptin-4 | 1.68e-04 | 6.23e-05 | NA |
2. P | P84223 | Cecropin-C | 2.68e-04 | 4.10e-07 | NA |
2. P | P01361 | Atrial gland peptide B | 1.07e-02 | 3.14e-05 | NA |
2. P | E2A6Z3 | Allatostatin C | 1.81e-04 | 4.38e-06 | NA |
2. P | O46541 | Natriuretic peptides B | 1.65e-03 | 4.16e-03 | NA |
2. P | P0CE37 | Apolipoprotein C-I, acidic form | 2.86e-03 | 1.10e-07 | NA |
2. P | P14531 | Delta-hormotoxin-Cpt1b | 9.53e-04 | 3.17e-03 | NA |
2. P | Q2PE74 | Interleukin-4 | 2.21e-03 | 2.89e-03 | NA |
2. P | P43443 | Neuromedin-B | 3.38e-03 | 2.82e-05 | NA |
2. P | P18145 | C-type natriuretic peptide | 2.14e-02 | 3.85e-04 | NA |
2. P | Q810H5 | Galanin-like peptide | 8.46e-02 | 4.19e-08 | NA |
2. P | P34405 | FMRFamide-like neuropeptide 23 | 3.95e-02 | 1.12e-07 | NA |
2. P | I7C2V3 | Spexin prohormone 1 | 9.93e-04 | 3.03e-09 | NA |
2. P | P86189 | Raniseptin-9 | 8.53e-04 | 5.88e-03 | NA |
2. P | Q91330 | Progonadoliberin-2 | 3.22e-02 | 3.23e-05 | NA |
2. P | P0DTG5 | Apolipoprotein C-I | 4.91e-04 | 3.54e-03 | NA |
2. P | P83056 | Kininogen-1 | 3.03e-03 | 2.79e-08 | NA |
2. P | Q9N0T2 | Calcitonin gene-related peptide 1 | 2.19e-03 | 2.99e-03 | NA |
2. P | V9QFH8 | Alpha-latrotoxin associated low molecular weight protein 2 | 3.12e-02 | 1.00e-02 | NA |
2. P | A0A193H365 | Cruzioseptin-7 | 5.09e-04 | 2.44e-04 | NA |
2. P | P10334 | Accessory gland-specific peptide 26Ab | 9.43e-02 | 2.64e-07 | NA |
2. P | B9TQX1 | Unique cartilage matrix-associated protein | 2.64e-04 | 8.15e-03 | NA |
2. P | P01507 | Cecropin-A | 2.50e-03 | 3.17e-03 | NA |
2. P | P55057 | Apolipoprotein C-IV | 1.89e-03 | 3.26e-05 | NA |
2. P | P81615 | Urocortin | 2.44e-04 | 6.59e-06 | NA |
2. P | A3EX95 | Non-structural protein 3a | NA | 7.79e-06 | NA |
2. P | Q6BEG7 | Appetite-regulating hormone | 1.11e-02 | 2.94e-03 | NA |
2. P | P0DSJ4 | U-myrmeciitoxin(01)-Mg1a | 4.56e-04 | 2.06e-03 | NA |
2. P | Q2V462 | Putative defensin-like protein 38 | 4.09e-02 | 3.87e-02 | NA |
2. P | P40756 | C-type natriuretic peptide 2 | 8.99e-04 | 1.87e-02 | NA |
2. P | Q766Y6 | Calcitonin receptor-stimulating peptide 3 | 2.11e-03 | 2.54e-05 | NA |
2. P | Q28358 | Guanylate cyclase activator 2B | 3.08e-02 | 5.92e-04 | NA |
2. P | Q27239 | Cecropin-A | 1.41e-03 | 1.39e-02 | NA |
2. P | Q2WCN7 | Pelophylaxin-2 | 5.87e-04 | 3.92e-04 | NA |
2. P | Q0TB41 | Uncharacterized protein YicS | 5.28e-02 | 1.25e-02 | NA |
2. P | P80344 | Cholecystokinin | 2.49e-02 | 1.64e-02 | NA |
2. P | P31529 | Sapecin-B | 1.08e-01 | 3.30e-02 | NA |
2. P | P0CE39 | Apolipoprotein C-I, acidic form | 3.33e-03 | 1.12e-07 | NA |
2. P | Q54B95 | Putative uncharacterized protein DDB_G0293808 | 1.23e-03 | 6.90e-03 | NA |
2. P | Q8AXR3 | C-type natriuretic peptide 1 | 1.86e-02 | 1.27e-04 | NA |
2. P | P0DTR9 | Apolipoprotein C-II | 1.22e-03 | 2.42e-04 | NA |
2. P | O93226 | Dermaseptin-A5 | 6.15e-03 | 9.06e-08 | NA |
2. P | P84276 | Palustrin-1c | 7.28e-04 | 6.96e-03 | NA |
2. P | P0CF78 | Apolipoprotein C-I, acidic form | 3.19e-03 | 5.20e-05 | NA |
2. P | P0DQC2 | U-scoloptoxin(15)-Sm3a | 1.80e-01 | 2.99e-03 | NA |
2. P | B4PPU4 | Protein Turandot A | 1.62e-03 | 2.05e-04 | NA |
2. P | Q5MGC9 | Defense protein 6 | 1.06e-02 | 1.13e-02 | NA |
2. P | P84222 | Cecropin-C | 2.71e-04 | 4.10e-07 | NA |
2. P | A0A5P9NYS6 | Dermaseptin-PT9 | 5.71e-04 | 5.62e-06 | NA |
2. P | P01562 | Interferon alpha-1/13 | 2.80e-03 | 2.13e-02 | NA |
2. P | P86040 | Raniseptin-7 | 1.07e-03 | 2.65e-03 | NA |
2. P | Q5JQD4 | Putative peptide YY-3 | 3.13e-03 | 4.03e-02 | NA |
2. P | P0DN50 | Teretoxin Tsu6.16 | 4.76e-03 | 1.54e-04 | NA |
2. P | Q9BPD9 | Conotoxin TsMLCL-04 | 1.54e-03 | 4.94e-08 | NA |
2. P | Q8NG41 | Neuropeptide B | 1.58e-01 | 2.25e-03 | NA |
2. P | Q80UG6 | ALK and LTK ligand 2 | 1.57e-02 | 5.50e-07 | NA |
2. P | O02686 | Gastrin | 1.37e-01 | 8.09e-04 | NA |
2. P | Q9UBU3 | Appetite-regulating hormone | 3.45e-02 | 1.86e-03 | NA |
2. P | Q31US3 | Uncharacterized protein YicS | 7.69e-02 | 1.69e-02 | NA |
2. P | P10601 | Pancreatic prohormone | 1.13e-02 | 8.58e-05 | NA |
2. P | Q0VC44 | Spexin | 4.27e-03 | 1.42e-07 | NA |
2. P | P18657 | Apolipoprotein C-I, basic form | 2.62e-03 | 3.50e-07 | NA |
2. P | Q9DET7 | Bombinins BLP-7/GH-2 | 5.55e-04 | 5.01e-03 | NA |
2. P | D0P0D8 | RxLR effector protein PITG_19617 | 1.33e-03 | 7.49e-06 | NA |
2. P | P55089 | Urocortin | 1.55e-04 | 1.03e-05 | NA |
2. P | Q9N0T3 | Calcitonin gene-related peptide 2 | 2.00e-03 | 1.00e-02 | NA |
2. P | E4VP07 | Venom antimicrobial peptide-6 | 9.20e-04 | 5.18e-04 | NA |
2. P | P0DQB6 | U-scoloptoxin(15)-Sm1a | 1.07e-02 | 4.91e-02 | NA |
2. P | Q8VD96 | Uteroglobin | 1.81e-03 | 9.51e-05 | NA |
2. P | P0DMF6 | Peptide Ctri9293 | 3.97e-03 | 2.65e-03 | NA |
2. P | P0DPH5 | Apolipoprotein C-I | 2.93e-04 | 1.31e-07 | NA |
2. P | P18656 | Apolipoprotein A-II | 5.20e-04 | 7.96e-08 | NA |
2. P | P22889 | Islet amyloid polypeptide | 1.25e-02 | 1.22e-03 | NA |
2. P | P58337 | Putative conjugal transfer lipoprotein XF_a0011.1 | 5.16e-03 | 9.07e-04 | NA |
2. P | O95399 | Urotensin-2 | 1.70e-02 | 1.03e-04 | NA |
2. P | P0DUJ5 | Pteroicidin-alpha | 5.30e-04 | 8.99e-04 | NA |
2. P | C0HKR1 | Adipokinetic prohormone type 2 | 7.60e-03 | 3.19e-08 | NA |
2. P | Q86PR5 | Cecropin-B1 | 6.36e-03 | 1.22e-03 | NA |
2. P | Q8HYC2 | Urotensin-2 | 1.60e-02 | 2.74e-05 | NA |
2. P | P0C0P5 | Neuropeptide S | 2.17e-02 | 1.56e-02 | NA |
2. P | P0DN52 | Teretoxin Tan6.2 | 1.00e-01 | 2.25e-04 | NA |
2. P | P0DME6 | Peptide Hp1036 | 3.48e-04 | 6.56e-03 | NA |
2. P | P08949 | Neuromedin-B | 3.66e-04 | 9.16e-08 | NA |
2. P | B1P1I4 | U31-theraphotoxin-Cg1b | 1.49e-02 | 8.18e-05 | NA |
2. P | D5KXG9 | Turripeptide UID-02 | 1.05e-02 | 8.40e-09 | NA |
2. P | Q8MUF4 | Cecropin-B | 1.86e-03 | 5.67e-06 | NA |
2. P | P80111 | Gastrin/cholecystokinin-like peptide | 6.34e-03 | 1.05e-04 | NA |
2. P | Q0N4U7 | Alpha/kappa-conotoxin-like pl14.1 | 3.68e-03 | 1.07e-02 | NA |
2. P | P86185 | Raniseptin-2 | 1.26e-04 | 6.08e-04 | NA |
2. P | P27917 | Apolipoprotein C-III | 2.33e-04 | 2.23e-02 | NA |
2. P | F6JWU8 | Conotoxin Lt28.2 | 5.20e-02 | 4.29e-02 | NA |
2. P | P19713 | Pro-MCH 1 | 2.10e-01 | 1.13e-02 | NA |
2. P | W2PED7 | RxLR effector protein PPTG_18954 | 1.90e-02 | 1.30e-06 | NA |
2. P | P0DPH6 | Apolipoprotein C-I | 2.87e-03 | 3.36e-04 | NA |
2. P | P24393 | Gastrin-releasing peptide | 2.44e-03 | 1.38e-02 | NA |
2. P | V9QER4 | Alpha-latrotoxin associated low molecular weight protein SGV242-280 | 8.46e-02 | 3.20e-02 | NA |
2. P | Q4U4N3 | Alpha-latrotoxin-associated low molecular weight protein-2 | 8.17e-03 | 3.72e-02 | NA |
2. P | D2Y2M3 | U3-theraphotoxin-Hhn1c | 7.64e-02 | 7.94e-04 | NA |
2. P | Q95JC3 | Liver-expressed antimicrobial peptide 2 | 2.35e-02 | 2.56e-05 | NA |
2. P | P47212 | Galanin peptides | 4.17e-02 | 5.34e-11 | NA |
2. P | Q805D6 | C-type natriuretic peptide 1 | 2.44e-03 | 1.43e-03 | NA |
2. P | P85832 | Orcokinin peptides | 5.41e-02 | 7.33e-04 | NA |
2. P | A0A172M416 | Secreted RxLR effector protein 9 | 1.01e-02 | 1.52e-03 | NA |
2. P | Q06590 | Cecropin-2 | 1.89e-04 | 1.84e-06 | NA |
2. P | P28674 | Pro-neuropeptide Y | 1.18e-02 | 9.31e-03 | NA |
2. P | C0HLG4 | Wasabi receptor toxin | 4.34e-02 | 1.60e-02 | NA |
2. P | Q32ZH9 | Beta-defensin 12 | 8.13e-02 | 5.01e-03 | NA |
2. P | Q9BP62 | Conotoxin VnMSGL-0121 | 3.37e-03 | 1.27e-02 | NA |
2. P | Q9GKY5 | Appetite-regulating hormone | 7.95e-02 | 9.68e-06 | NA |
2. P | Q32KM8 | Augurin | 9.17e-03 | 1.40e-02 | NA |
2. P | D2Y2M1 | U3-theraphotoxin-Hhn1a 12 | 1.51e-02 | 2.82e-02 | NA |
2. P | Q5Y4X9 | U2-agatoxin-Ao1g | 2.52e-03 | 2.07e-02 | NA |
2. P | Q90ZK3 | Dermaseptin-B7 | 2.08e-04 | 5.82e-04 | NA |
2. P | L7VIN3 | Cecropin-like peptide 1 | 1.52e-03 | 3.67e-08 | NA |
2. P | P86037 | Raniseptin-1 | 6.88e-04 | 1.21e-03 | NA |
2. P | Q6QN06 | Matrix Gla protein | 1.08e-02 | 3.30e-04 | NA |
2. P | D3JWK2 | Conotoxin Cal22a | 4.19e-02 | 3.30e-02 | NA |
2. P | P81486 | Dermaseptin-B4 | 1.79e-04 | 2.37e-06 | NA |
2. P | Q17128 | Hypertrehalosaemic prohormone | 9.18e-04 | 1.08e-09 | NA |
2. P | Q9PT75 | Dermatoxin-B1 | 4.89e-04 | 5.90e-06 | NA |
2. P | L0L3V3 | Frenatin 2.3S | 4.62e-03 | 1.27e-02 | NA |
2. P | P13083 | Pancreatic prohormone | 1.05e-02 | 1.63e-09 | NA |
2. P | P41475 | Uncharacterized 6.4 kDa protein in GP41-PNK intergenic region | NA | 3.49e-02 | NA |
2. P | Q868F8 | Allatostatin | 3.23e-02 | 3.23e-02 | NA |
2. P | Q0PGP2 | Androgen-binding protein homolog | 5.62e-03 | 2.68e-02 | NA |
2. P | A0A3B7TLI7 | RxLR effector protein BLR40 | 1.07e-02 | 3.20e-05 | NA |
2. P | Q7T3K9 | Dermaseptin-S6 | 1.48e-03 | 1.52e-03 | NA |
2. P | Q28207 | Islet amyloid polypeptide | 2.93e-02 | 1.58e-03 | NA |
2. P | P50720 | Hyphancin-3D | 3.92e-03 | 6.89e-04 | NA |
2. P | P0DMA7 | Apolipoprotein C-I, basic form (Fragment) | 2.18e-04 | 2.56e-03 | NA |
2. P | A0A6G9KJK9 | U10-myrmicitoxin-Mri1a | 4.09e-03 | 1.22e-02 | NA |
2. P | P33739 | Accessory gland-specific peptide 26Ab | 1.05e-01 | 2.66e-07 | NA |
2. P | P52880 | Uncharacterized protein F46C5.1 | 5.31e-04 | 8.42e-07 | NA |
2. P | P0DUQ7 | Conotoxin Pl071 | NA | 1.39e-06 | NA |
2. P | A7WNV5 | Esculentin-2PLa | 4.16e-03 | 3.05e-02 | NA |
2. P | P01354 | Gastrin | 6.28e-02 | 2.18e-05 | NA |
2. P | E1B230 | Esculentin-2CG1 | 4.97e-04 | 2.03e-03 | NA |
2. P | W4VS32 | Toxin ICK-15 | 5.99e-02 | 2.48e-02 | NA |
2. P | P56249 | Frenatin-3 | 2.62e-03 | 4.19e-02 | NA |
2. P | Q94990 | Cecropin-2 | 7.07e-04 | 6.63e-09 | NA |
2. P | A0A193H362 | Cruzioseptin-2 | 1.56e-04 | 1.65e-03 | NA |
2. P | Q9DGC9 | Progonadoliberin-2 | 2.64e-02 | 5.11e-07 | NA |
2. P | Q1ELT9 | M-zodatoxin-Lt1a | 1.18e-03 | 3.55e-02 | NA |
2. P | O24565 | CLAVATA3/ESR (CLE)-related protein ESR2 | 3.41e-02 | 2.86e-02 | NA |
2. P | P0C0P6 | Neuropeptide S | 1.86e-02 | 8.58e-05 | NA |
2. P | Q58T92 | Maximins y/Hw | 1.69e-03 | 1.19e-03 | NA |
2. P | Q2V4D6 | Putative defensin-like protein 33 | 2.30e-02 | 3.21e-04 | NA |
2. P | A0A096P2H6 | Apolipoprotein C-IV | 1.24e-03 | 1.50e-09 | NA |
2. P | E1B231 | Palustrin-2CG1 | 1.86e-04 | 5.15e-05 | NA |
2. P | Q9VET0 | Neuropeptide F | 2.05e-03 | 9.53e-07 | NA |
2. P | Q969E1 | Liver-expressed antimicrobial peptide 2 | 2.52e-02 | 1.91e-04 | NA |
2. P | O93453 | Dermaseptin-DA3 | 1.01e-03 | 3.30e-04 | NA |
2. P | P01350 | Gastrin | 4.39e-02 | 3.15e-08 | NA |
2. P | P48821 | Antibacterial peptide enbocin | 1.11e-04 | 1.89e-03 | NA |
2. P | P0CH90 | N.vectensis toxin 1 4 | 1.61e-02 | 1.76e-02 | NA |
2. P | P0DME8 | Peptide Hp1239 | 1.91e-03 | 1.67e-02 | NA |
2. P | Q9FEB4 | Phytosulfokines 5 | 2.90e-02 | 9.24e-05 | NA |
2. P | P0DMI9 | Antimicrobial peptide HsAp3 | 4.10e-04 | 3.81e-02 | NA |
2. P | P17559 | Uteroglobin | 1.98e-03 | 1.41e-06 | NA |
2. P | P85883 | Phylloseptin-Az3 | 9.15e-04 | 3.10e-02 | NA |
2. P | E2E4L2 | Goannatyrotoxin-Vere1 | 1.40e-02 | 2.21e-06 | NA |
2. P | Q3ECH9 | CLAVATA3/ESR (CLE)-related protein 18 | 5.52e-03 | 1.12e-02 | NA |
2. P | A8X7F0 | Chondroitin proteoglycan 8 | 1.21e-02 | 1.94e-02 | NA |
2. P | A8MTW9 | Putative uncharacterized protein ENSP00000380674 | 2.85e-04 | 1.45e-02 | NA |
2. P | Q9U657 | Mu-conotoxin-like PnMKLT1-014 | 6.35e-02 | 1.13e-02 | NA |
2. P | Q9BP66 | Conotoxin ArMSGL-011 | 6.57e-02 | 1.78e-02 | NA |
2. P | D3Z752 | Spexin | 1.30e-03 | 7.06e-06 | NA |
2. P | Q299E6 | Protein Turandot X | 8.26e-04 | 1.91e-03 | NA |
2. P | A0A2U3Y4D7 | Apolipoprotein C-II | 1.42e-03 | 4.89e-06 | NA |
2. P | C0HK02 | Ocellatin-PT7 | 9.04e-04 | 1.12e-07 | NA |
2. P | P10774 | Mating pheromone Er-1/Er-3 | 9.31e-03 | 6.47e-04 | NA |
2. P | Q8MIQ5 | Apolipoprotein A-II | 1.65e-04 | 5.54e-09 | NA |
2. P | Q9BPE1 | Conotoxin Vn5.5 | 8.69e-04 | 1.30e-05 | NA |
2. P | P07457 | Ice-structuring protein SP1-C | 9.79e-03 | 4.26e-02 | NA |
2. P | Q92097 | Progonadoliberin-3 (Fragment) | 2.57e-02 | 5.24e-06 | NA |
2. P | P25421 | Protachykinin | 1.43e-02 | 1.45e-02 | NA |
2. P | B1NWS4 | N.vectensis toxin 1 1 | 1.01e-02 | 2.70e-03 | NA |
2. P | O73811 | Progonadoliberin-2 | 8.30e-03 | 1.25e-09 | NA |
2. P | P64459 | Uncharacterized protein YncJ | 1.36e-04 | 3.99e-05 | NA |
2. P | P0DKM2 | Turripeptide OL179 | 2.64e-05 | 6.51e-03 | NA |
2. P | Q76IQ4 | Ghrelin | 2.47e-02 | 4.27e-09 | NA |
2. P | Q9PTA0 | Pro-neuropeptide Y | 7.15e-04 | 6.65e-05 | NA |
2. P | B2RZ42 | ALK and LTK ligand 2 | 1.80e-02 | 1.20e-07 | NA |
2. P | F6JWV2 | Conotoxin Lt28.6 | 1.37e-02 | 2.64e-02 | NA |
2. P | Q1R4S0 | Uncharacterized protein YicS | 8.27e-02 | 1.25e-02 | NA |
2. P | Q5Y4Y0 | U2-agatoxin-Ao1f | 8.36e-02 | 3.93e-02 | NA |
2. P | Q8WVF2 | Unique cartilage matrix-associated protein | 1.61e-04 | 1.17e-04 | NA |
2. P | P69155 | Pro-MCH 2 | 2.14e-01 | 1.64e-05 | NA |
2. P | O95968 | Secretoglobin family 1D member 1 | 3.84e-03 | 8.22e-03 | NA |
2. P | P50711 | Alpha-defensin 13 | 1.44e-01 | 2.75e-02 | NA |
2. P | A0A144LVM3 | Strongylocin 2 | 4.23e-02 | 7.66e-05 | NA |
2. P | P01261 | Calcitonin | 3.93e-03 | 2.67e-05 | NA |
2. P | Q8T112 | Cerebrin prohormone | 7.30e-03 | 4.43e-05 | NA |
2. P | Q6R799 | Uncharacterized protein ORF120 | NA | 2.04e-02 | NA |
2. P | Q23757 | Red pigment-concentrating prohormone | 8.98e-04 | 1.12e-03 | NA |
2. P | P0C848 | Turripeptide Gkn9.1 | 9.32e-02 | 8.50e-03 | NA |
2. P | B3P312 | Protein Turandot B1 | 4.71e-03 | 1.06e-04 | NA |
2. P | Q5Y4X4 | U2-agatoxin-Ao1l | 5.89e-02 | 9.70e-03 | NA |
2. P | D0NZA8 | RxLR effector protein PITG_18670 | 2.67e-03 | 4.98e-10 | NA |
2. P | Q2WCN8 | Pelophylaxin-1 | 2.11e-03 | 7.42e-06 | NA |
2. P | F7UI84 | Phylloseptin-S1 | 7.21e-04 | 1.45e-02 | NA |
2. P | P0DTG4 | Apolipoprotein C-I | 6.78e-04 | 1.01e-04 | NA |
2. P | Q5H8A3 | Neuromedin-S | 3.18e-02 | 7.95e-03 | NA |
2. P | O93452 | Dermaseptin-DA2 | 1.24e-04 | 1.02e-05 | NA |
2. P | P84900 | Phyllokininogen-1 | 1.28e-03 | 4.29e-02 | NA |
2. P | Q07334 | Islet amyloid polypeptide (Fragment) | 3.49e-03 | 8.93e-03 | NA |
2. P | Q91194 | Somatostatin-2 | 7.67e-03 | 2.20e-02 | NA |
2. P | P70668 | Guanylate cyclase activator 2B | 2.88e-02 | 1.42e-06 | NA |
2. P | P30368 | Interleukin-4 | 1.58e-03 | 6.56e-03 | NA |
2. P | Q7Z4H4 | Protein ADM2 | 2.15e-01 | 6.89e-04 | NA |
2. P | P07348 | Interferon alpha-1 | 4.46e-03 | 3.44e-02 | NA |
2. P | P60985 | Keratinocyte differentiation-associated protein | 9.42e-02 | 5.80e-10 | NA |
2. P | P0CE40 | Apolipoprotein C-I, basic form | 4.63e-04 | 7.40e-04 | NA |
2. P | Q58T60 | Maximins 5/H4 type 2 | 3.45e-04 | 3.84e-02 | NA |
2. P | P01351 | Gastrin | 2.04e-01 | 2.35e-05 | NA |
2. P | P55797 | Apolipoprotein C-IV | 8.50e-04 | 1.96e-08 | NA |
2. P | P0DP51 | Apolipoprotein C-I | 2.63e-05 | 1.68e-08 | NA |
2. P | P86546 | Osteocalcin | 1.65e-02 | 1.35e-06 | NA |
2. P | O16829 | Cecropin-C | 1.82e-03 | 4.28e-08 | NA |
2. P | B1B5I9 | Delta-stichotoxin-Shd3a | 1.76e-03 | 8.50e-03 | NA |
2. P | P16043 | Somatoliberin | 1.70e-04 | 1.21e-07 | NA |
2. P | P0C8W2 | Non-disulfide-bridged peptide 5.6 | 1.94e-02 | 1.13e-02 | NA |
2. P | P0DTH4 | Apolipoprotein C-IV | 6.66e-03 | 1.30e-05 | NA |
2. P | O62689 | Pro-MCH (Fragment) | 1.57e-03 | 3.28e-02 | NA |
2. P | B8XH50 | Amphipathic peptide Tx348 | 3.71e-03 | 5.23e-03 | NA |
2. P | Q64356 | Seminal vesicle secretory protein 6 | 3.84e-02 | 5.79e-03 | NA |